var title_f23_6_23648="Intestines bulging through hernia PI";
var content_f23_6_23648=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F76003&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F76003&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Intestines bulging through hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 618px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In some cases, a loop of intestine can poke through a hernia. Often surgeons can push the loop of intestine back in. But if the loop gets trapped or does not get enough blood, surgeons sometimes have to remove it and reconnect the two ends of intestine that are left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23648=[""].join("\n");
var outline_f23_6_23648=null;
var title_f23_6_23649="Yellow nail syndrome";
var content_f23_6_23649=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Yellow nail syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23649=[""].join("\n");
var outline_f23_6_23649=null;
var title_f23_6_23650="Patient information: Bone density testing (The Basics)";
var content_f23_6_23650=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15886\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/45/24275\">",
"         Bones affected by osteoporosis",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/59/12211\">",
"         Patient information: Paget disease of bone (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/29/1491\">",
"         Patient information: Bone density testing (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/49/25366\">",
"         Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bone density testing (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/bone-density-testing-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H27832139\">",
"      <span class=\"h1\">",
"       What is bone density testing?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bone density testing is one way doctors can check how strong your bones are.",
"     </p>",
"     <p>",
"      As people age, their bones often become less dense&mdash;thinner and more fragile (",
"      <a class=\"graphic graphic_figure graphicRef53181 \" href=\"UTD.htm?23/45/24275\">",
"       figure 1",
"      </a>",
"      ). Over time, this can lead to a disorder called osteoporosis, which makes bones weak. People who have osteoporosis have bones that can break too easily. For example, people with osteoporosis sometimes break a bone just from falling down.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832146\">",
"      <span class=\"h1\">",
"       What is bone density testing used for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors do bone density testing for 2 reasons:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        To see if a person has osteoporosis or is at risk for the disorder",
"       </li>",
"       <li>",
"        To see if treatments for osteoporosis are working",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832153\">",
"      <span class=\"h1\">",
"       Who should get bone density testing?",
"      </span>",
"      &nbsp;&mdash;&nbsp;All women age 65 and older should have bone density testing at least once. Bone density testing might also be appropriate for some men who are older than 70 and some women who are younger than 65 but who have gone through menopause, meaning they have stopped having their monthly periods. Doctors sometimes check bone density in people who fit these descriptions if they are at high risk of breaking a bone. Things that increase your risk of breaking a bone include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Having already broken a bone as an adult",
"       </li>",
"       <li>",
"        Taking medicines called steroids for a long time",
"       </li>",
"       <li>",
"        Weighing less than 127 pounds",
"       </li>",
"       <li>",
"        Having rheumatoid arthritis",
"       </li>",
"       <li>",
"        Having a parent who broke a hip after a minor injury",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832160\">",
"      <span class=\"h1\">",
"       Are there different types of bone density tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The different types of bone density tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Dual-energy X-ray absorptiometry (DXA)",
"        </strong>",
"        &ndash; This is the most useful and reliable bone density test. It is a special kind of X-ray that gives off very little radiation. DXA gives reliable measures of bone density in different parts of the body, such as the spine, hip, and wrist. DXA is the best test to diagnose osteoporosis, predict the chances that you will break a bone, and check how well treatment is working.",
"       </li>",
"       <li>",
"        <strong>",
"         Quantitative computerized tomography (CT) &ndash;",
"        </strong>",
"        This is another special kind of X-ray. It gives reliable measurements of bone density in the spine. It gives off more radiation than DXA. Doctors don&rsquo;t use this test to diagnose osteoporosis.",
"       </li>",
"       <li>",
"        <strong>",
"         Ultrasound testing",
"        </strong>",
"        &ndash; Ultrasound can be used to measure the bone density of the heel. This test can help find out a person&rsquo;s risk of breaking a bone. But doctors don&rsquo;t use this test to diagnose osteoporosis or to follow changes in bone density over time.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832167\">",
"      <span class=\"h1\">",
"       What happens during a DXA test?",
"      </span>",
"      &nbsp;&mdash;&nbsp;During DXA, you lie on a table. Then an X-ray machine scans one of your bones. The test doesn&rsquo;t hurt or make you uncomfortable. You don&rsquo;t need to take any pills or get any shots. The whole thing takes 5 to 10 minutes.",
"     </p>",
"     <p>",
"      Even though DXA is a type of X-ray, it gives off very little radiation. During a DXA you get about the same amount of radiation that an average person gets from the environment in one day. After the test, your bones get a &ldquo;score.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832174\">",
"      <span class=\"h1\">",
"       What do the results mean?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The results of a bone density test are called \"T\" and \"Z\" scores. Of the 2 numbers, the T-score is more important.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Normal bone density",
"        </strong>",
"        &ndash; People with normal bone density have a T-score between +1 and -1. People who have a score in this range do not usually need treatment. Still, it makes sense for them do things to prevent bone loss. For instance, they should eat foods rich in calcium and vitamin D, and do exercise.",
"       </li>",
"       <li>",
"        <strong>",
"         Osteopenia",
"        </strong>",
"        (also known as low bone mass) &ndash; Osteopenia is the term doctors use when bone density is lower than normal but not as low as it gets with osteoporosis. A person with osteopenia does not yet have osteoporosis but is at risk of developing it. People with osteopenia have a T-score between -1.1 and -2.4. They usually need to do things to prevent bone loss. Sometimes that means taking medicines.",
"       </li>",
"       <li>",
"        <strong>",
"         Osteoporosis",
"        </strong>",
"        &ndash; People with osteoporosis have a T-score of -2.5 or less. If you discover that you have osteoporosis, there are lots of things you can do to lower the chances that you will break a bone. For instance, you can take osteoporosis medicines and calcium and vitamin D supplements. You can also exercise.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832181\">",
"      <span class=\"h1\">",
"       Do I need to have bone density testing again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your test shows that you do not have osteoporosis today, you might need to have the test again later. Ask your doctor or nurse if and when you should be tested again.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27832203\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/59/12211?source=see_link\">",
"       Patient information: Paget disease of bone (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"       Patient information: Bone density testing (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"       Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/6/23650?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15886 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-9DBBEBA25B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23650=[""].join("\n");
var outline_f23_6_23650=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832139\">",
"      What is bone density testing?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832146\">",
"      What is bone density testing used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832153\">",
"      Who should get bone density testing?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832160\">",
"      Are there different types of bone density tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832167\">",
"      What happens during a DXA test?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832174\">",
"      What do the results mean?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832181\">",
"      Do I need to have bone density testing again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27832203\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15886\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/45/24275\">",
"      Bones affected by osteoporosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=related_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/59/12211?source=related_link\">",
"      Patient information: Paget disease of bone (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23651="Patient information: Toxic hepatitis (The Basics)";
var content_f23_6_23651=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17191\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"         Organs inside the abdomen (belly)",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19066\">",
"          The different parts of a medicine label (Drug Facts)",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/49/33554\">",
"         Patient information: Acetaminophen poisoning (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/28/39361\">",
"         Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/33/25105\">",
"         Patient information: Alternative medicine (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/25/24979\">",
"         Patient information: Cirrhosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/30/483\">",
"         Patient information: Dealing with side effects from medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/21/36179\">",
"         Patient information: Giving your child over-the-counter medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/17/34066\">",
"         Patient information: Jaundice in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/15/40178\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?43/21/44371\">",
"         Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/3/44084\">",
"         Patient information: Cirrhosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/39/4721\">",
"         Patient information: Liver biopsy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/13/2262\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Toxic hepatitis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/toxic-hepatitis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H31829196\">",
"      <span class=\"h1\">",
"       What is toxic hepatitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Toxic hepatitis is a condition that affects the liver. The liver is a big organ in the upper right side of the belly (",
"      <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      &ldquo;Hepatitis&rdquo; is a general term that means inflammation of the liver. It has different causes. In toxic hepatitis, the inflammation is caused by medicines, herbal or diet supplements, or harmful chemicals.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829211\">",
"      <span class=\"h1\">",
"       What medicines can cause toxic hepatitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Both prescription and over-the-counter medicines can cause toxic hepatitis. Some common examples are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"         Acetaminophen",
"        </a>",
"        (sample brand name: Tylenol&reg;)",
"       </li>",
"       <li>",
"        NSAIDs, which are a large group of medicines that includes",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample names: Advil&reg;, Motrin&reg;) and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sample brand names: Aleve&reg;, Naprosyn&reg;)",
"       </li>",
"       <li>",
"        Certain antibiotics",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Toxic hepatitis can happen within days of taking a medicine or supplement. It can also happen after people have been taking a medicine or supplement for months.",
"     </p>",
"     <p>",
"      For some medicines, like",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      , toxic hepatitis happens if people take too much of the medicine. For other medicines, like antibiotics, toxic hepatitis happens when people take a normal dose. But it&rsquo;s rare for toxic hepatitis to happen when people take a normal dose of medicine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829226\">",
"      <span class=\"h1\">",
"       What are the symptoms of toxic hepatitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people with toxic hepatitis have no symptoms. They find out they have it after their doctor does routine blood tests or blood tests for another reason. For instance, doctors sometimes do blood tests if people are taking a medicine that has a high chance of causing toxic hepatitis.",
"     </p>",
"     <p>",
"      When toxic hepatitis causes symptoms, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Nausea and vomiting",
"       </li>",
"       <li>",
"        Not feeling hungry",
"       </li>",
"       <li>",
"        Jaundice, which is when the skin or white part of the eye turns yellow",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829241\">",
"      <span class=\"h1\">",
"       Should I see my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Call your doctor or nurse if you have the symptoms above, especially if you started taking a new medicine or supplement.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829256\">",
"      <span class=\"h1\">",
"       Is there a test for toxic hepatitis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To check for liver inflammation, your doctor or nurse will do blood tests to measure substances called &ldquo;liver enzymes.&rdquo;",
"     </p>",
"     <p>",
"      Your doctor or nurse might do other tests to make sure you don&rsquo;t have another liver condition. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An imaging test &ndash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"       <li>",
"        A liver biopsy &ndash; For this test, the doctor uses a needle to remove a small sample of tissue from the liver. Then another doctor looks at the sample under a microscope.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829271\">",
"      <span class=\"h1\">",
"       How is toxic hepatitis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main treatment for toxic hepatitis is to avoid the medicine, supplement, or chemical that inflamed your liver.",
"     </p>",
"     <p>",
"      Most people do not need any other treatment, because their liver will heal on its own. But it can take weeks to months for the liver to heal. During this time, your doctor or nurse will probably do repeat blood tests to check your liver enzymes.",
"     </p>",
"     <p>",
"      While your liver is healing, your doctor or nurse will also probably recommend that you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Avoid drinking alcohol.",
"       </li>",
"       <li>",
"        Check with him or her before you take any medicines or supplements.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sometimes, toxic hepatitis causes severe liver damage and liver failure. This happens most often when people overdose on",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      . People with liver failure usually need a liver transplant, which is surgery to replace a diseased liver with a healthy liver.",
"     </p>",
"     <p>",
"      People who get toxic hepatitis after taking a medicine or supplement for a long time can sometimes get scarring of the liver, called &ldquo;cirrhosis.&rdquo; People with severe cirrhosis might also need a liver transplant.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829294\">",
"      <span class=\"h1\">",
"       Can toxic hepatitis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To help prevent toxic hepatitis, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Follow your doctor&rsquo;s instructions when you take prescription medicines.",
"       </li>",
"       <li>",
"        Read the Drug Facts label on all over-the-counter medicines you take (",
"        <a class=\"graphic graphic_figure graphicRef73468 \" href=\"UTD.htm?18/39/19066\">",
"         figure 2",
"        </a>",
"        ). This label tells you what the recommended dose is. Do not take more than the recommended dose.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You should also read the Drug Facts label to find out what the medicine&rsquo;s &ldquo;active ingredient&rdquo; is. The active ingredient is the part of the medicine that treats symptoms. Medicines that treat different conditions can have the same active ingredient. Do not take 2 medicines with the same active ingredient, because it could cause an overdose. For instance, if you are taking",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      to treat a fever or pain, do not also take a cold medicine with acetaminophen in it.",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Avoid drinking too much alcohol.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H31829309\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/49/33554?source=see_link\">",
"       Patient information: Acetaminophen poisoning (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=see_link\">",
"       Patient information: Dealing with side effects from medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/33/25105?source=see_link\">",
"       Patient information: Alternative medicine (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/25/24979?source=see_link\">",
"       Patient information: Cirrhosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/17/34066?source=see_link\">",
"       Patient information: Jaundice in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/28/39361?source=see_link\">",
"       Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=see_link\">",
"       Patient information: Giving your child over-the-counter medicines (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=see_link\">",
"       Patient information: Cirrhosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=see_link\">",
"       Patient information: Liver biopsy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/21/44371?source=see_link\">",
"       Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/6/23651?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17191 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23651=[""].join("\n");
var outline_f23_6_23651=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829196\">",
"      What is toxic hepatitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829211\">",
"      What medicines can cause toxic hepatitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829226\">",
"      What are the symptoms of toxic hepatitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829241\">",
"      Should I see my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829256\">",
"      Is there a test for toxic hepatitis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829271\">",
"      How is toxic hepatitis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829294\">",
"      Can toxic hepatitis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31829309\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17191\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"      Organs inside the abdomen (belly)",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19066\">",
"       The different parts of a medicine label (Drug Facts)",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/49/33554?source=related_link\">",
"      Patient information: Acetaminophen poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/21/44371?source=related_link\">",
"      Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/28/39361?source=related_link\">",
"      Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/33/25105?source=related_link\">",
"      Patient information: Alternative medicine (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=related_link\">",
"      Patient information: Cirrhosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/25/24979?source=related_link\">",
"      Patient information: Cirrhosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=related_link\">",
"      Patient information: Dealing with side effects from medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=related_link\">",
"      Patient information: Giving your child over-the-counter medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/17/34066?source=related_link\">",
"      Patient information: Jaundice in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=related_link\">",
"      Patient information: Liver biopsy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23652="Hypertrophic lichen planus lesion";
var content_f23_6_23652=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypertrophic lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This scaly, hyperpigmented plaque is a lesion of hypertrophic lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23652=[""].join("\n");
var outline_f23_6_23652=null;
var title_f23_6_23653="Melanonychia ethnic";
var content_f23_6_23653=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ethnic melanonychia commonly seen in dark-skinned individuals",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple longitudinal melanonychia band are commonly seen in dark-skinned individuals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23653=[""].join("\n");
var outline_f23_6_23653=null;
var title_f23_6_23654="Perineal urethrostomy";
var content_f23_6_23654=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64813&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64813&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perineal urethrostomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23654=[""].join("\n");
var outline_f23_6_23654=null;
var title_f23_6_23655="Human milk feeding and fortification of human milk for premature infants";
var content_f23_6_23655=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Human milk feeding and fortification of human milk for premature infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Richard J Schanler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23655/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/6/23655/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants have greater nutritional needs to achieve optimal growth in the neonatal period than at any other time of their life. There are several reasons for this:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants born at the beginning of the third trimester of pregnancy often are growth-restricted because of decreased intrauterine nutrient deposition.",
"     </li>",
"     <li>",
"      Medical conditions including hypotension, hypoxia, acidosis, infection, and surgery increase metabolic energy requirements and thus nutrient needs [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Additional impediments to growth are physiologic immaturity of the gastrointestinal tract including decreased gastrointestinal motility and reduced intestinal enzyme activity, and therapies such as corticosteroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nutritional support helps to correct growth restriction at birth and to achieve an appropriate rate of weight gain, which is almost twice that of a term infant [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Parenteral nutrition is necessary for infants whose immaturity or medical condition precludes enteral feeding.",
"   </p>",
"   <p>",
"    Enteral nutrition can be provided to premature infants with either human milk or commercial preterm formulas. The American Academy of Pediatrics (AAP) recommends human milk as the preferred feeding for all infants, although supplementation, utilizing human milk fortifiers, is required to meet the nutritional needs of premature newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/4\">",
"     4",
"    </a>",
"    ]. The feeding of human milk to preterm infants including the use of human milk fortifiers is discussed in this topic review.",
"   </p>",
"   <p>",
"    Although human milk is the preferred feeding for premature infants, preterm-formula is an appropriate option especially if there is an inadequate supply of mother's milk or other extenuating circumstances. The different components of both human milk and preterm formula and how they meet the needs of the premature infant are discussed elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=see_link\">",
"     \"Nutritional composition of human milk and preterm formula for the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to enteral feedings in the premature infant including determination of nutrient and energy requirements, methods of feeding, and assessment of feeding intolerance is discussed elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=see_link\">",
"     \"Approach to enteral nutrition in the premature infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=see_link\">",
"     \"Nutritional composition of human milk for full-term infants\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The management of growth of preterms including nutrition at the time and after discharge from the neonatal intensive care unit is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link\">",
"     \"Growth management in preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ADVANTAGES OF HUMAN MILK",
"    </span>",
"    &nbsp;&mdash;&nbsp;The beneficial effects of human milk are discussed in detail elsewhere. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Improved gastrointestinal function, digestion, and absorption of nutrients",
"     </li>",
"     <li>",
"      Improved cognitive and visual development",
"     </li>",
"     <li>",
"      Improved host defense with reduced rates of infection (eg, sepsis, necrotizing enterocolitis, and urinary tract infection)",
"     </li>",
"     <li>",
"      Enhanced maternal psychological well-being and maternal-infant bonding",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=see_link\">",
"     \"Nutritional composition of human milk for full-term infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"     \"Infant benefits of breastfeeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the benefits noted above, human milk promotes more rapid attainment of full enteral feeds and shorter duration of hospitalization in premature infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Improved host defense",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most significant impacts of human milk in premature infants is the improvement of host defense. Premature infants fed human milk have reduced rates of infections and necrotizing enterocolitis than those who receive formula [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Possible explanations for these beneficial effects include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Presence of maternal antibodies (ie, immunoglobulins G [IgG] and secretory A [sIgA]) in breast milk provided by the enteromammary immune system. Mothers exposed to their own infants by skin-to-skin contact may also make specific antibodies to nosocomial pathogens.",
"     </li>",
"     <li>",
"      Human milk feeding may result in fecal flora comprised of less pathogenic microorganisms than nursery-acquired pathogens.",
"     </li>",
"     <li>",
"      Human milk also contains other factors, including lactoferrin, lysozyme, oligosaccharides, cytokines, enzymes, growth factors, nucleotides, and cellular components, that may be important in host defense.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Protection against necrotizing enterocolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human milk also decreases the incidence of necrotizing enterocolitis (NEC) as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study showed NEC was six to ten times less common in preterm infants fed human milk than those fed formula and three times less common in those fed a combination of formula and human milk than those fed formula alone [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 202 preterm infants, patients who received high proportions of human milk (greater than 50 percent of total enteral feedings) compared to those with low human milk intake (less than 50 percent) in the first 14 days of life had a decrease rate of NEC (3.2 versus 10 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a third study of extremely low birth weight infants (birth weight below 1000 g), an average intake of mothers' own milk (plus human milk fortifier) of 50",
"      <span class=\"nowrap\">",
"       ml/kg",
"      </span>",
"      per day was associated with a lower incidence of NEC and sepsis compared to preterm formula [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of certain human milk components may protect premature infants against NEC, and the absence of these components may potentiate NEC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link&amp;anchor=H4#H4\">",
"     \"Infant benefits of breastfeeding\", section on 'Anti-microbial components'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunoglobulins &ndash; The importance of IgA and IgG was demonstrated in a randomized trial in which oral administration of IgA and IgG in amounts similar to those contained in human milk reduced the incidence of necrotizing enterocolitis in formula-fed premature infants compared to controls (0 versus 7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/10\">",
"       10",
"      </a>",
"      ]. Infants fed the immunoglobulin preparation had greater fecal excretion of IgA than did controls, suggesting the mixture provided local protection of the gastrointestinal tract. The fecal excretion rate of IgA in infants supplemented with IgA is similar to the excretion rate observed in premature infants fed human milk, and greater than the rate in formula fed infants without supplementation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acetylhydrolase &ndash; The presence of acetylhydrolase antagonizes platelet-activating factor, a major trigger for NEC in premature infants. The oligosaccharide acts as a prebiotic constituent resulting in the development of a less pathogenic fecal flora.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LIMITATIONS OF HUMAN MILK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although human milk is the preferred form of nutrition for premature infants with numerous advantages over bovine milk, there are limitations of the ability of exclusive human milk feedings to meet the nutritional requirements of these infants. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inadequate milk supply of the mother",
"     </li>",
"     <li>",
"      Volume restrictions limiting intake of the infant",
"     </li>",
"     <li>",
"      Nutrient limitations of human milk",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inadequate supply",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mother's milk production must be sufficient to meet her infant's need in order to provide exclusive human milk feedings. A major impediment to exclusive human milk feeding for premature infants is the difficulty many mothers experience in providing sufficient quantities of milk. Explanations have been given for low milk production and include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maternal stress",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      illness",
"     </li>",
"     <li>",
"      Difficulty maintaining a supply without a suckling infant",
"     </li>",
"     <li>",
"      Biological immaturity of the mammary gland of mothers of premature infants",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Volume restrictions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume of intake in premature infants may be limited by the inability to feed ad libitum or by medical conditions that warrant fluid restriction such as bronchopulmonary dysplasia or patent ductus arteriosus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Nutrient limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another important limitation of human milk is that intake of some essential nutrients is inadequate to meet the needs of the premature infant. Unfortified human milk does not supply sufficient quantities of nutrients such as protein, calcium, phosphorus, iron and vitamins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=see_link\">",
"     \"Nutritional composition of human milk and preterm formula for the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, other factors may lead to insufficient quantities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    variability of human milk content. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Changes in composition related to storage",
"     </li>",
"     <li>",
"      Alterations of delivery with the use of feeding tubes (ie, adsorption of nutrients by tubing)",
"     </li>",
"     <li>",
"      Differences in composition related to the length of lactation (ie, decreased protein content with increased length of lactation)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     STRATEGIES TO MEET NUTRITIONAL NEEDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mother's milk is the preferred form of nutrition for premature infants. It is important for each center to educate and support mothers to provide breast milk for their preterm infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13657?source=see_link\">",
"     \"Breast milk expression for the preterm infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=see_link\">",
"     \"Breastfeeding the preterm infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, mother's milk may be inadequate related to insufficient supply",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    insufficient quantity of nutrients to meet the nutritional needs of the premature infant.",
"   </p>",
"   <p>",
"    If these limitations are present, we recommend the following approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For inadequate supply, fortified mother's human milk is either mixed or alternated with preterm formula.",
"     </li>",
"     <li>",
"      For restricted volume intake, mother's human milk is fortified to increase caloric and nutrient intake. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fortification of human milk'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      For insufficient nutrients, mother's human milk is fortified to increase nutrient intake. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fortification of human milk'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Preterm formula versus donor milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;When mother&rsquo;s human milk is unavailable despite adequate lactation support, pasteurized donor milk or preterm formula are alternatives. Donor milk is usually pasteurized because of the risk of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/11\">",
"     11",
"    </a>",
"    ], which decreases the activity of many of the functional bioactive factors in milk [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Quality control is important in the collection, pasteurization, storage, and distribution of donor human milk but adds to the cost of donor milk.",
"   </p>",
"   <p>",
"    In randomized and nonrandomized clinical trials and systemic reviews, donor milk compared with preterm formula was associated with a lower risk of feeding intolerance and NEC but also more abnormalities in biochemical indices of nutritional status and a slower rate of growth [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. A subsequent report comparing an appropriately fortified yet exclusive donor human milk diet with diets of mother&rsquo;s own milk and bovine-based milk products demonstrated that the exclusive donor human milk diet was associated with a lower rate of NEC and surgery for NEC compared with the other two diets [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/19\">",
"     19",
"    </a>",
"    ]. In a second phase of this investigation, mothers who did not intend to provide their own breast milk to their infants allowed their child to be randomly assigned to either preterm formula or exclusive donor. Although the number of subjects was small in the second phase of the study, there were significantly more days of parenteral nutrition and NEC surgery in the group that was fed preterm formula [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/21\">",
"     21",
"    </a>",
"    ]. These data confirmed the results of the first phase of this study.",
"   </p>",
"   <p>",
"    Based on the data demonstrating the benefit of donor milk on reducing the risk of NEC, the 2012 American Academy of Pediatrics policy statement on breastfeeding recommended the use of pasteurized donor milk, which is appropriately fortified, if mother&rsquo;s own milk is unavailable or its use is contraindicated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     FORTIFICATION OF HUMAN MILK",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the reasons mentioned above, very low birth weight premature infants (usually born weighing less than 1500 g) fed unfortified human milk during hospitalization and after discharge do not grow optimally and have nutritional deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/6,22-27\">",
"     6,22-27",
"    </a>",
"    ]. Premature infants fed fortified mother's milk receive more protein, energy (kcal), and minerals in lower volumes compared to unfortified milk.",
"   </p>",
"   <p>",
"    This is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nutritional outcome data demonstrate that premature infants fed fortified human milk have greater intakes of protein and minerals in less volumes of milk, and experience greater gains in weight and increments in linear growth than infants fed unfortified human milk exclusively [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/9,28-33\">",
"       9,28-33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Protein and energy supplementation are associated with improved rates of weight gain as well as improved indices of protein nutritional status (ie, blood urea nitrogen, serum albumin, and transthyretin).",
"     </li>",
"     <li>",
"      Balance study data indicate that the use of fortified human milk approaches is greater than the net nutrient retention expected for intrauterine rates of accretion [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/28,30,31,34-36\">",
"       28,30,31,34-36",
"      </a>",
"      ]. Mineral supplementation during hospitalization prevents a decrease in linear growth and increases bone mineralization during and beyond the neonatal period [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/37\">",
"       37",
"      </a>",
"      ]. An additional study showed that supplementation with calcium and phosphorus resulted in normalization biochemical indices of mineral status including serum calcium, phosphorus, and alkaline phosphatase activity, and urinary excretion of calcium and phosphorus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/38\">",
"       38",
"      </a>",
"      ]. Sodium supplementation results in normalization of serum sodium [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fat absorption, however, has been lower than expected with the use of some fortifiers [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/2,38\">",
"       2,38",
"      </a>",
"      ]. Fat absorption may be augmented by newer human milk fortifiers that contain fat [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon these data, our recommendation is that multinutrient fortification of human milk be used preferentially in the enteral nutrition of premature infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Tolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Questions have been raised as to whether the addition of bovine-derived human milk fortifiers affects feeding tolerance in premature infants. In one study, the use of fortified human milk was",
"    <strong>",
"     not",
"    </strong>",
"    associated with feeding intolerance when compared with control supplemented human milk containing only phosphate and vitamins [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/32\">",
"     32",
"    </a>",
"    ]. Evaluation of feeding intolerance included the presence of abdominal distention, vomiting, changes in stool frequency, or volume of gastric aspirate. Comparisons with preterm formula also have been made and no major differences in feeding intolerance have been attributed to human milk fortification [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/9,40\">",
"     9,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=see_link&amp;anchor=H15#H15\">",
"     \"Approach to enteral nutrition in the premature infant\", section on 'Feeding intolerance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Effect on infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is of interest that despite the large quantity of added nutrients supplied by a human milk fortifier, the protective effect seems to be unimpaired. Most contemporary studies demonstrating lower rates of infection-related events were conducted in premature infants receiving fortified human milk.",
"   </p>",
"   <p>",
"    There are limited data addressing this issue including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study showed that nutrient fortification did not change the concentration of IgA in fortified compared to nonfortified milk [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/41\">",
"       41",
"      </a>",
"      ]. In addition, bacterial colony counts did not increase with 24 hours of refrigerator storage of fortified human milk.",
"     </li>",
"     <li>",
"      Another study addressed concerns that the addition of iron to human milk fortifiers would bind bacteriostatic human milk proteins, thereby decreasing the protective effect of human milk [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/42\">",
"       42",
"      </a>",
"      ]. This study showed that there was no difference in bacterial growth in human milk supplemented with one of two fortifiers that differed in their iron content (1.44 versus 0.35 mg per 100 mL of human milk, respectively) during 72 hours of refrigeration. Total bacterial growth in human milk fortified with either preparation declined with increasing refrigerated storage time for 72 hours.",
"     </li>",
"     <li>",
"      A third study demonstrated that in vitro inhibition of bacterial growth around a disk of filter paper saturated with human milk did not change with the addition of human milk fortifier. However, when iron in the form of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/62/15334?source=see_link\">",
"       ferrous sulfate",
"      </a>",
"      was added to the fortifier and human milk, bacterial inhibition of growth was significantly reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Necrotizing enterocolitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;It appears the risk of necrotizing enterocolitis (NEC) is not increased with the use of fortified human milk in preterm infants. This was illustrated by a 2004 Cochrane meta-analysis, which was reviewed in 2009, that demonstrated no difference in the incidence of NEC in infants receiving fortified human milk versus those receiving unfortified human milk (relative risk 1.33, 95% 0.7-2.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other studies suggest that fortified human milk is more protective than preterm formula. This is illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 212 preterm infants (birth weight &lt;1500 g), fortified human milk-fed infants had a lower incidence of documented infection compared to formula-fed infants (29 versus 47 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 108 preterm infants (gestational age &lt;30 weeks), infants fed exclusively fortified human milk had a significantly lower incidence of NEC, late-onset sepsis, fewer positive blood cultures, and less antibiotic usage than those fed preterm formula [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23655/abstract/9\">",
"       9",
"      </a>",
"      ]. They also had a shorter duration of hospitalization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that fortified human milk has a similar effect on the incidence of NEC compared with unfortified human milk and provides enhanced protection compared with preterm formula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Commercial fortifiers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human milk fortifiers (HMF) are designed to be mixed with human milk and most are available in powder form. A variety of fortifiers is available globally. Micronutrient and vitamin content of fortifiers, especially those used globally, may vary and therefore individualization of supplements might be needed. These nutrient preparations contain protein, carbohydrate, calcium, phosphorus, magnesium, sodium, zinc, copper, and multivitamins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Duration of fortification",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no published data on the length of time that human milk should be fortified. In our practice, human milk fortification is discontinued when infants receive all their feedings orally and are growing well without any evidence of nutritional issues (eg, abnormal alkaline phosphatase, phosphorus, BUN, or albumin).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mother's milk is the preferred form of nutrition for premature infants. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Advantages of human milk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      However, mother's milk may be inadequate related to insufficient maternal supply, restricted volume intake,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      insufficient quantity of nutrients for premature infants. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Limitations of human milk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If these limitations are present, we recommend the following approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For inadequate maternal supply, fortified mother's human milk is either mixed or alternated with preterm formula. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=see_link\">",
"       \"Nutritional composition of human milk and preterm formula for the premature infant\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H11\">",
"       'Fortification of human milk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For restricted volume intake, mother's human milk is fortified to increase caloric and nutrient intake. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fortification of human milk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For insufficient nutrients, mother's human milk is fortified to increase nutrient intake. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fortification of human milk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/1\">",
"      Hay WW Jr, Lucas A, Heird WC, et al. Workshop summary: nutrition of the extremely low birth weight infant. Pediatrics 1999; 104:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/2\">",
"      Schanler RJ, Garza C, Nichols BL. Fortified mothers' milk for very low birth weight infants: results of growth and nutrient balance studies. J Pediatr 1985; 107:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/3\">",
"      Butte NF, Garza C, Smith EO, Nichols BL. Human milk intake and growth in exclusively breast-fed infants. J Pediatr 1984; 104:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/4\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/5\">",
"      Narayanan I, Prakash K, Bala S, et al. Partial supplementation with expressed breast-milk for prevention of infection in low-birth-weight infants. Lancet 1980; 2:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/6\">",
"      Contreras-Lemus J, Flores-Huerta S, Cisneros-Silva I, et al. [Morbidity reduction in preterm newborns fed with milk of their own mothers]. Bol Med Hosp Infant Mex 1992; 49:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/7\">",
"      Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/8\">",
"      Sisk PM, Lovelady CA, Dillard RG, et al. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/9\">",
"      Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/10\">",
"      Eibl MM, Wolf HM, F&uuml;rnkranz H, Rosenkranz A. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 1988; 319:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/11\">",
"      Cohen RS, Xiong SC, Sakamoto P. Retrospective review of serological testing of potential human milk donors. Arch Dis Child Fetal Neonatal Ed 2010; 95:F118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/12\">",
"      Lepri L, Del Bubba M, Maggini R, et al. Effect of pasteurization and storage on some components of pooled human milk. J Chromatogr B Biomed Sci Appl 1997; 704:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/13\">",
"      Koenig A, de Albuquerque Diniz EM, Barbosa SF, Vaz FA. Immunologic factors in human milk: the effects of gestational age and pasteurization. J Hum Lact 2005; 21:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/14\">",
"      Ewaschuk JB, Unger S, O'Connor DL, et al. Effect of pasteurization on selected immune components of donated human breast milk. J Perinatol 2011; 31:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/15\">",
"      Van Gysel M, Cossey V, Fieuws S, Schuermans A. Impact of pasteurization on the antibacterial properties of human milk. Eur J Pediatr 2012; 171:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/16\">",
"      Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 2005; 116:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/17\">",
"      Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007; 92:F169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/18\">",
"      Morales Y, Schanler RJ. Human milk and clinical outcomes in VLBW infants: how compelling is the evidence of benefit? Semin Perinatol 2007; 31:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/19\">",
"      Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/20\">",
"      Quigley MA, Henderson G, Anthony MY, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007; :CD002971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/21\">",
"      Cristofalo EA, Schanler RJ, Blanco CL, et al. Exclusive human milk vs preterm formula: Randomized trial in extremely preterm infants. Pediatr Res 2011; 70:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/22\">",
"      Kumar SP, Sacks LM. Hyponatremia in very low-birth-weight infants and human milk feedings. J Pediatr 1978; 93:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/23\">",
"      Atkinson SA, Bryan MH, Anderson GH. Human milk feeding in premature infants: protein, fat, and carbohydrate balances in the first two weeks of life. J Pediatr 1981; 99:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/24\">",
"      Atkinson SA, Radde IC, Anderson GH. Macromineral balances in premature infants fed their own mothers' milk or formula. J Pediatr 1983; 102:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/25\">",
"      T&ouml;nz O, Schubiger G. Feeding of very-low-birth-weight infants with breast-milk enriched by energy, nitrogen and minerals: FM85. Helv Paediatr Acta 1985; 40:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/26\">",
"      Cooper PA, Rothberg AD, Pettifor JM, et al. Growth and biochemical response of premature infants fed pooled preterm milk or special formula. J Pediatr Gastroenterol Nutr 1984; 3:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/27\">",
"      Gross SJ. Growth and biochemical response of preterm infants fed human milk or modified infant formula. N Engl J Med 1983; 308:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/28\">",
"      Polberger SK, Axelsson IA, R&auml;ih&auml; NC. Growth of very low birth weight infants on varying amounts of human milk protein. Pediatr Res 1989; 25:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/29\">",
"      Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev 2004; :CD000343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/30\">",
"      Greer FR, McCormick A. Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr 1988; 112:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/31\">",
"      Schanler RJ, Abrams SA. Postnatal attainment of intrauterine macromineral accretion rates in low birth weight infants fed fortified human milk. J Pediatr 1995; 126:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/32\">",
"      Lucas A, Fewtrell MS, Morley R, et al. Randomized outcome trial of human milk fortification and developmental outcome in preterm infants. Am J Clin Nutr 1996; 64:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/33\">",
"      Miller J, Makrides M, Gibson RA, et al. Effect of increasing protein content of human milk fortifier on growth in preterm infants born at &lt;31 wk gestation: a randomized controlled trial. Am J Clin Nutr 2012; 95:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/34\">",
"      Schanler RJ, Garza C, Smith EO. Fortified mothers' milk for very low birth weight infants: results of macromineral balance studies. J Pediatr 1985; 107:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/35\">",
"      Horsman A, Ryan SW, Congdon PJ, et al. Bone mineral accretion rate and calcium intake in preterm infants. Arch Dis Child 1989; 64:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/36\">",
"      Kashyap S, Schulze KF, Forsyth M, et al. Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk. Am J Clin Nutr 1990; 52:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/37\">",
"      Abrams SA, Schanler RJ, Tsang RC, Garza C. Bone mineralization in former very low birth weight infants fed either human milk or commercial formula: one-year follow-up observation. J Pediatr 1989; 114:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/38\">",
"      Schanler RJ, Garza C. Improved mineral balance in very low birth weight infants fed fortified human milk. J Pediatr 1988; 112:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/39\">",
"      Reis BB, Hall RT, Schanler RJ, et al. Enhanced growth of preterm infants fed a new powdered human milk fortifier: A randomized, controlled trial. Pediatrics 2000; 106:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/40\">",
"      Moody GJ, Schanler RJ, Lau C, Shulman RJ. Feeding tolerance in premature infants fed fortified human milk. J Pediatr Gastroenterol Nutr 2000; 30:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/41\">",
"      Jocson MA, Mason EO, Schanler RJ. The effects of nutrient fortification and varying storage conditions on host defense properties of human milk. Pediatrics 1997; 100:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/42\">",
"      Santiago MS, Codipilly CN, Potak DC, Schanler RJ. Effect of human milk fortifiers on bacterial growth in human milk. J Perinatol 2005; 25:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/43\">",
"      Ovali F, Cift&ccedil;i I, Cetinkaya Z, B&uuml;k&uuml;lmez A. Effects of human milk fortifier on the antimicrobial properties of human milk. J Perinatol 2006; 26:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23655/abstract/44\">",
"      Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998; 102:E38.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5050 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-217.16.9.173-E29AE5AA73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23655=[""].join("\n");
var outline_f23_6_23655=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ADVANTAGES OF HUMAN MILK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Improved host defense",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Protection against necrotizing enterocolitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LIMITATIONS OF HUMAN MILK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inadequate supply",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Volume restrictions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Nutrient limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      STRATEGIES TO MEET NUTRITIONAL NEEDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Preterm formula versus donor milk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FORTIFICATION OF HUMAN MILK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Tolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Effect on infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Necrotizing enterocolitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Commercial fortifiers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Duration of fortification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=related_link\">",
"      Approach to enteral nutrition in the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13657?source=related_link\">",
"      Breast milk expression for the preterm infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/12/36040?source=related_link\">",
"      Breastfeeding the preterm infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=related_link\">",
"      Growth management in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/28/458?source=related_link\">",
"      Nutritional composition of human milk and preterm formula for the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=related_link\">",
"      Nutritional composition of human milk for full-term infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23656="Flow cytometry for the diagnosis of primary immunodeficiencies";
var content_f23_6_23656=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Flow cytometry for the diagnosis of primary immunodeficiencies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23656/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23656/contributors\">",
"     James Verbsky, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23656/contributors\">",
"     Trivikram Dasu, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23656/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23656/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23656/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23656/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/6/23656/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flow cytometry is a powerful technique for the measurement of multiple characteristics of individual cells within heterogeneous populations. This review gives an overview of the technical aspects of flow cytometry and highlights some of its uses in the diagnosis of primary immunodeficiencies. Each of these immunodeficiencies is discussed in greater detail separately in specific topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNICAL ASPECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A basic flow cytometer consists of five main components: a flow cell, a laser, optical components, detectors to amplify signals, and an",
"    <span class=\"nowrap\">",
"     electronics/computer",
"    </span>",
"    system. With these five components, the flow cytometer is capable of performing instantaneous measurements by passing thousands of cells per second through a laser beam and capturing the emerging light from each cell as it passes through the interrogation point. Any suspended cell or particle ranging from 0.2 to 150 micrometers in size is suitable for analysis. Analyses to determine cellular characteristics, such as size, granularity, viability, and immunophenotyping, are the most common types of studies done.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Immunophenotyping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunophenotyping is a technique used to characterize the makeup of cell populations by detecting cellular protein expression. Immunophenotyping uses an antibody specific for the antigen of interest that is conjugated to a fluorescent compound known as a fluorophore or fluorochrome (",
"    <a class=\"graphic graphic_figure graphicRef68067 \" href=\"UTD.htm?27/31/28147\">",
"     figure 1",
"    </a>",
"    ). These fluorescent compounds absorb energy from the laser source causing an electron to be raised to a higher energy level. The excited electron quickly returns to its ground state, emitting the excess energy as a photon of light of a characteristic wavelength that is detected by the flow cytometer. Different fluorochromes are excited by different wavelengths of light and emit light at different wavelengths. Thus, it is possible to simultaneously detect several different antigens on a cell by using lasers of different wavelengths and filters of specific wavelengths to detect the fluorescent emission. As an example, current flow cytometers typically have four lasers of different wavelengths, with each laser paired to three different filters to allow for up to 12 different analyses at once.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Data collection and analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each cell is analyzed by the following parameters as the cell suspension passes through the flow cytometer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The intensity of the forward scatter (FSC) of light, which is a reflection of cell size",
"     </li>",
"     <li>",
"      The intensity of the side scatter of light (SSC), which is a reflection of cell granularity",
"     </li>",
"     <li>",
"      The intensity of light emitted by each fluorochrome, which reflects the level of expression of the antigen of interest",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The results are typically presented by two dimensional dot plots or one dimensional histograms. As an example, flow cytometric analysis of peripheral blood by FSC (ie, size) and SSC (ie, granularity) yields a characteristic two dimensional plot that distinguishes different cell populations (",
"    <a class=\"graphic graphic_figure graphicRef72579 \" href=\"UTD.htm?31/47/32501\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neutrophils are large and highly granular and therefore exhibit high SSC and high FSC signal",
"     </li>",
"     <li>",
"      Monocytes are large, but less granular. Thus, they exhibit lower SSC signal, but similar FSC signal compared with neutrophils",
"     </li>",
"     <li>",
"      Lymphocytes are the smallest and least granular of these cells, and therefore exhibit the lowest SSC and FSC signals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The level of expression of specific antigens can be examined in each of the populations defined by FSC and SSC profiles when flow cytometry is combined with fluorescent staining using antibodies against these antigens. As an example, when peripheral blood is stained with antibodies to CD15 (a neutrophil antigen) and CD14 (a monocyte antigen), three populations of cells are detected; a population of cells that only express CD15 (neutrophils), a population of cells that only express CD14 (monocytes), and a population of cells that express neither CD15 nor CD14 (",
"    <a class=\"graphic graphic_figure graphicRef51538 \" href=\"UTD.htm?11/31/11763\">",
"     figure 3",
"    </a>",
"    ). The percentage of each of these populations is used together with a complete blood count (CBC) to determine the absolute numbers of the different cell populations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF PRIMARY IMMUNODEFICIENCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary immunodeficiencies (PIDs) are a group of inherited disorders that can affect cells of the innate or adaptive immune systems [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/1\">",
"     1",
"    </a>",
"    ]. Flow cytometry is an essential tool in the diagnosis of immunodeficiencies. Its use is not limited to PIDs, since this methodology may be used to evaluate the immune system in secondary or acquired immunodeficiencies, such as those that may occur during viral infections (eg, HIV infection), post-bone marrow transplantation, during chemotherapy, and during immunosuppression for systemic autoimmunity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Defects in lymphocyte numbers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A CBC with differential is an essential first step in the workup of suspected primary immunodeficiencies, although this test does not determine the different lymphocyte subsets. Flow cytometry enables qualitative and quantitative enumeration of lymphocyte subsets, including CD4 and CD8 positive T cells, B cells, and NK cells (",
"    <a class=\"graphic graphic_figure graphicRef54176 \" href=\"UTD.htm?34/37/35412\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     T cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Markedly diminished numbers of T cells, with or without diminished numbers of B and NK cells, is a hallmark of severe combined immunodeficiency (SCID) (",
"    <a class=\"graphic graphic_figure graphicRef66983 \" href=\"UTD.htm?28/5/28753\">",
"     figure 5",
"    </a>",
"    ). SCID can be divided into several subtypes based upon the cell types that are deficient. As examples, mutations in CD3, CD45, or IL-7 receptor alpha (IL7RA) result in T-B+NK+ SCID; mutations in the recombinase activating genes (RAG) or Artemis result in T-B-NK+ SCID; mutations in adenosine deaminase (ADA) result in T-B-NK- SCID; and mutations in JAK3 or the gamma chain of the IL-2 receptor (IL2RG) result in T-B+NK-SCID. The subtype of SCID can only be determined by flow cytometry using markers specific for T cells (CD3), B cells (CD19), or NK cells (CD56). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lymphocyte enumeration is also used to determine T cell counts in children with DiGeorge syndrome, also known as 22q11 deletion syndrome. Analysis of T cell numbers is important, because T cell counts correlate with mortality in these individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/2\">",
"     2",
"    </a>",
"    ]. Affected individuals exhibit varying degrees of defects in the development of the thymus. Most patients with DiGeorge have mild defects in T cell numbers and are not clinically immunodeficient. However, a small percentage of them have complete absence of thymic function and profound immunodeficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link\">",
"     \"DiGeorge syndrome: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Regulatory T cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunodysregulation, polyendocrinopathy, and enteropathy X-linked (IPEX) is a disorder causing widespread autoimmune manifestations. Mutations in the forkhead transcription factor Foxp3 are responsible for this disease. Foxp3 is crucial to the development, survival, and effector function of regulatory T (Treg) cells, a cell population essential to immune regulation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/3\">",
"     3",
"    </a>",
"    ]. Treg cells account for approximately 5 to 10 percent of peripheral blood CD4+ T cells. Treg cells also express high levels of CD25, the high affinity binding subunit of the IL-2 receptor, and low levels of CD127, a subunit of the IL-7 receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/4\">",
"     4",
"    </a>",
"    ]. Use of antibodies to CD4, CD25, CD127, and Foxp3 allows for the determination of the percentage of Treg cells in peripheral blood from these patients (",
"    <a class=\"graphic graphic_figure graphicRef63330 \" href=\"UTD.htm?17/19/17713\">",
"     figure 6",
"    </a>",
"    ). IPEX-like diseases can also be caused by deficiencies in CD25 or STAT5b, key signal transduction subunits of the IL-2 receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25850?source=see_link\">",
"     \"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     B cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe reduction in all serum immunoglobulin (Ig) isotypes with profoundly diminished or absent B cells are hallmarks of X-linked agammaglobulinemia (XLA). Patients with XLA present in early childhood with recurrent infections, particularly with encapsulated bacteria and chronic enteroviral infections. XLA is caused by mutations in the Bruton's tyrosine kinase (BTK) gene, leading to a developmental block at the pre-B cell stage of B cell development in the bone marrow that results in near complete deficiency of all mature B cells. B cell enumeration is performed using the pan B cell markers CD19 or CD20, and this number is typically very low in XLA. Intracellular expression of the BTK protein can be analyzed in monocytes to confirm loss of expression of the BTK protein, since patients with XLA typically lack B cells (",
"    <a class=\"graphic graphic_figure graphicRef82104 \" href=\"UTD.htm?35/61/36820\">",
"     figure 7",
"    </a>",
"    ). Women who carry the mutated allele express normal numbers of B cells and normal levels of BTK due to non-random X-chromosome inactivation, but only about 50 percent of their monocytes express BTK. Thus, the percent of monocytes expressing BTK can be used to determine the carrier status in relatives of affected children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=see_link\">",
"     \"Agammaglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autosomal recessive (AR) agammaglobulinemia presents with a clinical phenotype similar to XLA, except that patients typically have an earlier onset of disease and more severe complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/9\">",
"     9",
"    </a>",
"    ]. AR agammaglobulinemia is cause by mutations in genes contributing to the maturation and function of B cells. BTK expression is normal in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=see_link\">",
"     \"Agammaglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Defects in T cell function",
"    </span>",
"    &nbsp;&mdash;&nbsp;T cell function can be assessed by a variety of assays using flow cytometry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Hyper IgM syndrome (HIGM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIGM is characterized by recurrent infections and very low levels of serum IgG, IgE, and IgA, with normal or elevated IgM. The most common form of HIGM is X-linked hyper IgM syndrome (XHIM) caused by mutations in the CD40 ligand (CD40L, also called CD154) gene. CD40L expressed on activated CD4+ T cells interacts with CD40 on B cells resulting in B cell activation, proliferation, immunoglobulin class switch recombination, and affinity maturation. Surface expression of CD40L on CD4+ T cells can be measured by in vitro activation of peripheral blood by phorbol esters and calcium ionophore that induce the expression of CD40L (",
"    <a class=\"graphic graphic_figure graphicRef61633 \" href=\"UTD.htm?16/17/16657\">",
"     figure 8",
"    </a>",
"    ). The failure to detect CD40L on activated cells is the basis of a functional flow cytometric assay to diagnose XHIM [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, the expression of CD40 on B cells can also be analyzed since defective CD40 expression is known to be one of the causes of autosomal recessive HIGM syndrome (AR-HIGM) (",
"    <a class=\"graphic graphic_figure graphicRef61633 \" href=\"UTD.htm?16/17/16657\">",
"     figure 8",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Autoimmune lymphoproliferative syndrome (ALPS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;ALPS, also known as Canale-Smith syndrome, is caused by genetic defects in proteins involved in the Fas-mediated apoptotic pathway. ALPS patients present with lymphadenopathy, hepatosplenomegaly, and autoimmune cytopenias, and are at high risk of developing lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/11\">",
"     11",
"    </a>",
"    ]. ALPS is categorized into Ia, Ib, IIa, IIb subtypes due to gene mutations in",
"    <span class=\"nowrap\">",
"     Fas/CD95,",
"    </span>",
"    Fas ligand (FasL), caspase10, and caspase8, respectively. Normally, &lt;1 percent of T cells that express the T cell receptor (TCR) alpha and beta chains do NOT also express the CD4 or CD8 coreceptors. These cells are called double negative T cells (DNTs). In ALPS, the number of TCR alpha beta DNTs is increased (",
"    <a class=\"graphic graphic_figure graphicRef82246 \" href=\"UTD.htm?17/43/18100\">",
"     figure 9",
"    </a>",
"    ). Additionally, these TCR alpha beta DNT cells coexpress the B cell antigen B220. Evans syndrome has features of ALPS (eg, autoimmune cytopenias), therefore it is important to rule out ALPS in this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5735?source=see_link&amp;anchor=H9#H9\">",
"     \"Apoptosis and autoimmune disease\", section on 'Autoimmune lymphoproliferative syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=see_link&amp;anchor=H28#H28\">",
"     \"Autoimmune hemolytic anemia in children\", section on 'Evans syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Hyper-immunoglobulin E syndrome (HIES)",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIES is an autosomal dominant disease characterized by pulmonary infections, staphylococcal abscesses, eczema, bone and connective tissue abnormalities, and elevated serum IgE levels. The defects in HIES are caused by missense mutations in the transcription factor STAT3 which is required to induce CD4+ T cells to produce IL-17a, a cytokine important in the generation of effective immune responses to bacteria and fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/13\">",
"     13",
"    </a>",
"    ]. A flow cytometry based functional assay measures the ability of T cells to synthesize IL-17a (",
"    <a class=\"graphic graphic_figure graphicRef64269 \" href=\"UTD.htm?29/49/30495\">",
"     figure 10",
"    </a>",
"    ). This response is impaired in patients with HIES syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32153?source=see_link\">",
"     \"Hyperimmunoglobulin E syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7730509\">",
"    <span class=\"h3\">",
"     X-linked lymphoproliferative (XLP) syndrome and X-linked inhibitor of apoptosis (XIAP) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;XLP is a rare X-linked disorder presenting with lymphohistiocytosis, often following Epstein-Barr virus (EBV) infection. It is also associated with hypogammaglobulinemia and EBV-associated lymphomas. This severe, life-threatening, primary immune deficiency disorder requires hematopoietic stem cell transplantation for cure. XLP is caused by mutations in the",
"    <em>",
"     SH2D1A",
"    </em>",
"    gene that encodes the signaling lymphocyte activation molecule (SLAM)-associated protein (SAP). X-linked inhibitor of apoptosis (XIAP) deficiency, caused by mutations in",
"    <em>",
"     BIRC4",
"    </em>",
"    gene, also presents with lymphohistiocytosis. XIAP deficiency is also associated with inflammatory bowel disease. Deficient expression of SAP or XIAP proteins in lymphocytes can be used to test for XLP and XIAP deficiency, respectively (",
"    <a class=\"graphic graphic_figure graphicRef58462 \" href=\"UTD.htm?17/38/18016\">",
"     figure 11",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. In addition, NK cell cytotoxicity with defective CD107 expression can be used to test for XLP, since SAP is required to activate cytotoxic T cells (",
"    <a class=\"graphic graphic_figure graphicRef52576 \" href=\"UTD.htm?4/51/4916\">",
"     figure 12",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/38/33384?source=see_link\">",
"     \"X-linked lymphoproliferative disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=see_link&amp;anchor=H19715226#H19715226\">",
"     \"Hemophagocytic lymphohistiocytosis\", section on 'XIAP (BIRC4)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7730525\">",
"    <span class=\"h3\">",
"     Wiskott-Aldrich syndrome (WAS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;WAS is a congenital X-linked disorder characterized by the triad of bleeding due to thrombocytopenia, eczema, and frequent infections. There is an overlap of symptoms in WAS patients with a closely related disease, X-linked thrombocytopenia and congenital X-linked neutropenia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/18\">",
"     18",
"    </a>",
"    ]. The WAS protein is important for actin polymerization of immune cells upon activation, and can affect both T and B cell responses. Deficient expression of WAS protein in lymphocytes is indicative of WAS (",
"    <a class=\"graphic graphic_figure graphicRef81683 \" href=\"UTD.htm?13/21/13648\">",
"     figure 13",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/19\">",
"     19",
"    </a>",
"    ]. Flow cytometry can also be used to evaluate heterozygosity carrier status in mothers of affected male patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36313?source=see_link\">",
"     \"Wiskott-Aldrich syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Defects in B cell function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defects in B cell function are associated with upper respiratory infections and infectious diarrhea due to impaired immunoglobulin production. It is important to determine the maturational status of B cells in addition to measuring B cell numbers. B cells go through a maturational program from na&iuml;ve B cells (characterized by the expression of IgD, but lacking the memory marker CD27) to memory B cells (IgD+CD27+) and switched memory B cells (IgD-CD27+) upon antigen exposure (",
"    <a class=\"graphic graphic_figure graphicRef52576 \" href=\"UTD.htm?4/51/4916\">",
"     figure 12",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Common Variable Immunodeficiency (CVID)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CVID is a relatively common PID that represents a heterogeneous group of diseases presenting with recurrent infections in both pediatric and adult patients. Affected individuals present with recurrent infections, but can also exhibit lymphoproliferative and autoimmune manifestations. Laboratory findings include low IgG and low IgM or IgA with variable numbers of absolute B cell numbers. Genetic defects in the genes TACI, BAFFR, and ICOS account for CVID in a small percentage of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/21\">",
"     21",
"    </a>",
"    ]. Flow cytometric analysis of individuals with CVID reveals normal to low B and T cell numbers with reduced switched memory B cells (&lt;1 to 2 percent of CD19+ B cells) (",
"    <a class=\"graphic graphic_figure graphicRef52576 \" href=\"UTD.htm?4/51/4916\">",
"     figure 12",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=see_link\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further categorization of CVID types has been developed by flow cytometric-based classification schemes to better understand the phenotypic patterns of memory B cell subsets in CVID patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. These classification schemes involve analysis of additional antigens (eg, CD21, CD38), which may help to predict other complications of CVID, such as splenomegaly or granulomatous disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cytotoxic lymphocyte defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Natural killer (NK) cells and CD8+ T cells are cytotoxic cells that possess the ability to recognize and kill virally infected cells and tumor cells. Upon activation of NK cells or CD8+ T cells, cytotoxic granules translocate toward the point of contact with the target cell and fuse with the plasma membrane, releasing the cytotoxic molecules perforin and granzymes into the intercellular space. This process is facilitated by several proteins including Rab27a, Munc13-4, and Lyst1. Perforin then facilitates the delivery of granzymes into the target cell and the initiation of apoptosis. Gene mutations in proteins involved in this process may result in a severe immune activation syndrome, termed hemophagocytic lymphohistiocytosis (HLH), in response to viral infections, particularly cytomegalovirus and Epstein-Barr virus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/24\">",
"     24",
"    </a>",
"    ]. Flow cytometry can be used to detect deficiencies in these molecules, as well as to test for defects in killing of target cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=see_link\">",
"     \"NK cell deficiency syndromes: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=see_link\">",
"     \"Hemophagocytic lymphohistiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cytotoxicity assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cytotoxic pathway can be evaluated using a flow cytometry based NK cell cytotoxicity assay, since NK cells exhibit the ability to kill tumor cells without preactivation or other manipulation. Briefly, a target tumor cell line (K562) is labeled with a fluorescent dye (CFSE) so that these target cells can be identified from the subject's effector cells. These target cells are incubated with increasing ratios of peripheral blood mononuclear cells (PBMCs) containing NK cells. Upon apoptosis target cells shrink (reflected by a reduction in cell size) and incorporate the fluorescent dye (7-AAD), which intercalates into the DNA of apoptotic cells (",
"    <a class=\"graphic graphic_figure graphicRef55165 \" href=\"UTD.htm?35/27/36280\">",
"     figure 14",
"    </a>",
"    ). Defective killing of effector cells indicates cytotoxic lymphocyte dysfunction and possible mutation in gene(s) in the pathway described above. Flow cytometry can then be used to analyze the expression of cytotoxic molecules (eg, perforin), as well as determine if there are defects in the degranulation of these cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Expression of cytotoxic molecules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defective cytotoxicity is the hallmark of HLH. The expression of perforin as detected by intracellular flow cytometry is an important analysis in evaluating patients with defective cytotoxicity, since 20 to 30 percent of HLH patients present with defects in perforin expression (",
"    <a class=\"graphic graphic_figure graphicRef68336 \" href=\"UTD.htm?5/59/6065\">",
"     figure 15",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Genetic mutational analysis should be performed if perforin expression is normal to examine other mutations associated with HLH (Rab27a, Munc13-4, and Lyst1) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/24,27\">",
"     24,27",
"    </a>",
"    ]. These proteins are critical to the translocation and fusion of cytotoxic granules to the plasma membrane. Measurement of surface expression of CD107a (LAMP-1, lysosomal associated membrane protein-1) can be used for assessment of the cytotoxic pathway, since this protein is displayed on the cell surface upon cytotoxic granule fusion with the plasma membrane. Normally approximately 5 to 10 percent of NK cells express CD107a on the cell surface when in contact with the target cells (",
"    <a class=\"graphic graphic_figure graphicRef79019 \" href=\"UTD.htm?32/40/33408\">",
"     figure 16",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Innate immune system defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophil defects are associated with skin infections, abscesses, poor pus formation, and defects in wound healing. Neutrophils must adhere to the endothelium at sites of infection, migrate toward the infectious organisms, and then phagocytose and kill the organisms. Defects in any step along this pathway can result in disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link\">",
"     \"Primary disorders of phagocytic function: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Leukocyte adhesion deficiencies (LAD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Movement of leukocytes from the vascular space to the active site of inflammation involves extravasation of neutrophils by rolling and adhering to the endothelial cell surface. Leukocyte adhesion deficiency (LAD I) is an autosomal recessive disorder due to mutations in the beta-2 integrin CD18. LAD II, also an autosomal recessive disorder, occurs due to mutations in a fucose transporter that causes sialyl Lewis",
"    <span class=\"nowrap\">",
"     X/CD15a",
"    </span>",
"    deficiency. Both CD15 and CD18 are involved in the rolling and firm adhesion of neutrophils to endothelium. Flow cytometry can assess the expression of CD18 and CD15 and should be tested in any infant with poor wound healing, abscesses, or skin infections (",
"    <a class=\"graphic graphic_figure graphicRef74505 \" href=\"UTD.htm?27/48/28431\">",
"     figure 17",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22953?source=see_link\">",
"     \"Leukocyte adhesion deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Chronic granulomatous disease (CGD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CGD is a rare immune deficiency, but one of the most common phagocyte defects. CGD is characterized by the absence or severe reduction of the neutrophil oxidative burst that is required to produce molecules, such as superoxide, that are critical to the killing of microorganisms. In CGD, microbial killing is defective due to mutations in one of four known components of the NADPH oxidase complex. These diseases are X-linked",
"    <span class=\"nowrap\">",
"     (gp91phox/CYBB)",
"    </span>",
"    or autosomal recessive",
"    <span class=\"nowrap\">",
"     (p22phox/CYBA,",
"    </span>",
"    <span class=\"nowrap\">",
"     p47phox/NCF1,",
"    </span>",
"    <span class=\"nowrap\">",
"     p67phox/NCF2).",
"    </span>",
"   </p>",
"   <p>",
"    CGD",
"    patients suffer from a wide variety of recurrent infections typically caused by catalase positive bacteria and fungi. Laboratory diagnosis of CGD is made based upon reduced oxidation of the fluorescent dye dihydrorhodamine (DHR123). In this assay, neutrophils are loaded with DHR123, then stimulated with phorbol esters or soluble bacterial peptides (eg, fMLP) (",
"    <a class=\"graphic graphic_figure graphicRef57778 \" href=\"UTD.htm?31/18/32032\">",
"     figure 18",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/28\">",
"     28",
"    </a>",
"    ]. A strong shift in fluorescence is typically seen when the neutrophils are activated. This fluorescence is either absent or severely reduced in patients with CGD. This assay can also be used to detect carrier status of female relatives of patients with X-linked CGD, since CGD carriers will exhibit a bimodal peak due to random X-inactivation. However, skewed X-inactivation may alter this finding, especially if the carrier has some CGD features. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=see_link\">",
"     \"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Mendelian susceptibility to mycobacterial diseases (MSMD)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with defects in the generation of or responsiveness to interferon (IFN)-gamma are susceptible to infections with Mycobacteria and Salmonella, since IFN-gamma plays a major role in the activation of macrophage and the clearance of intracellular pathogens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Macrophages and dendritic cells secrete interleukin (IL)-12 upon intracellular bacterial infection. IL-12 then binds to the IL-12 receptor on CD4+ T cells, thereby inducing production of IFN-gamma. IFN-gamma produced by CD4+ T cells binds to the IFN-gamma receptor (IFNGR) on macrophages, leading to activation of signal transducer and activator of transcription 1 (STAT1). This results in activated macrophages capable of eliminating intracellular microbes. Defects in any of these proteins can lead to increased susceptibility to",
"    <em>",
"     Mycobacteria",
"    </em>",
"    and",
"    <em>",
"     Salmonella",
"    </em>",
"    .",
"   </p>",
"   <p>",
"    Characterized defects in this pathway include mutations in IFNGR, STAT1, IL12RB1, and IL12B.",
"   </p>",
"   <p>",
"    Flow cytometry is useful in the evaluation of patients with increased susceptibility to mycobacterial infection (",
"    <a class=\"graphic graphic_figure graphicRef69926 \" href=\"UTD.htm?28/35/29237\">",
"     figure 19",
"    </a>",
"    ). Determination of IFN-&gamma;R1 (CD119) and IL-12R&beta;1 (CD212) expression are used to look for mutations that result in loss of protein expression. Other assays such as phosphorylation of STAT1 and STAT4 in response to IFN-gamma and IL-12 stimulation, respectively, are used to test whether the receptors are functional [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Toll-like receptor (TLR) defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to recognize infectious microorganisms is a critical first step in the generation of an immune response. TLRs are a group of receptors that recognize pathogen-associated molecular patterns (PAMPs) of bacteria, viruses, and fungi and mediate this effect. Defects in the TLR signaling pathway proteins IL-1 receptor associated kinase-4 (IRAK-4) and MyD88 are implicated in invasive pneumococcal disease, and mutations in genes involved in TLR3 signaling are associated with herpetic encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Flow cytometry can be used to assess the response of immune cells to TLR ligands by measuring the intracellular production of cytokines (",
"    <a class=\"graphic graphic_figure graphicRef53498 \" href=\"UTD.htm?26/36/27200\">",
"     figure 20",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23656/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"     \"Toll-like receptors: Roles in disease and therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flow cytometry is most commonly used in cellular analysis to determine characteristics, such as size, granularity, viability, and cellular protein expression (immunophenotyping). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Technical aspects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flow cytometry is an essential tool in the diagnosis of primary immunodeficiencies. Lymphocyte subset enumeration can be determined by measuring expression of certain cell surface molecules. Flow cytometry-based functional assays are also available to test for defects in immune pathways. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis of primary immunodeficiencies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/1\">",
"      International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009; 124:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/2\">",
"      Eberle P, Berger C, Junge S, et al. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome. Clin Exp Immunol 2009; 155:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/3\">",
"      Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005; 116:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/4\">",
"      Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/5\">",
"      Caudy AA, Reddy ST, Chatila T, et al. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007; 119:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/6\">",
"      Cohen AC, Nadeau KC, Tu W, et al. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol 2006; 177:2770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/7\">",
"      Kanegane H, Futatani T, Wang Y, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 2001; 108:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/8\">",
"      Futatani T, Miyawaki T, Tsukada S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998; 91:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/9\">",
"      Conley ME. Early defects in B cell development. Curr Opin Allergy Clin Immunol 2002; 2:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/10\">",
"      O'Gorman MR, Zaas D, Paniagua M, et al. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers. Clin Immunol Immunopathol 1997; 85:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/11\">",
"      Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001; 98:2466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/12\">",
"      Teachey DT, Manno CS, Axsom KM, et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 2005; 105:2443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/13\">",
"      Ma CS, Chew GY, Simpson N, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008; 205:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/14\">",
"      Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/15\">",
"      Tabata Y, Villanueva J, Lee SM, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 2005; 105:3066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/16\">",
"      Marsh RA, Villanueva J, Zhang K, et al. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry B Clin Cytom 2009; 76:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/17\">",
"      Marsh RA, Bleesing JJ, Filipovich AH. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J Immunol Methods 2010; 362:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/18\">",
"      Ochs HD. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes. Immunol Res 2009; 44:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/19\">",
"      Kawai S, Minegishi M, Ohashi Y, et al. Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 2002; 260:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/20\">",
"      Yamada M, Ariga T, Kawamura N, et al. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells. J Immunol 2000; 165:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/21\">",
"      Park MA, Li JT, Hagan JB, et al. Common variable immunodeficiency: a new look at an old disease. Lancet 2008; 372:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/22\">",
"      Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/23\">",
"      Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008; 74:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/24\">",
"      Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol 2006; 6:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/25\">",
"      Weren A, Bonnekoh B, Schraven B, et al. A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes. J Immunol Methods 2004; 289:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/26\">",
"      Godoy-Ramirez K, Franck K, Gaines H. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J Immunol Methods 2000; 239:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/27\">",
"      Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006; 38:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/28\">",
"      Roesler J, Hecht M, Freihorst J, et al. Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry. Eur J Pediatr 1991; 150:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/29\">",
"      Fleisher TA, Dorman SE, Anderson JA, et al. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999; 90:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/30\">",
"      Uzel G, Frucht DM, Fleisher TA, Holland SM. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol 2001; 100:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/31\">",
"      Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/32\">",
"      Picard C, Puel A, Bonnet M, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003; 299:2076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/33\">",
"      Hirschfeld AF, Bettinger JA, Victor RE, et al. Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol 2007; 122:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23656/abstract/34\">",
"      Deering RP, Orange JS. Development of a clinical assay to evaluate toll-like receptor function. Clin Vaccine Immunol 2006; 13:68.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3937 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-125.39.66.147-DB4EA05A22-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23656=[""].join("\n");
var outline_f23_6_23656=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNICAL ASPECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Immunophenotyping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Data collection and analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS OF PRIMARY IMMUNODEFICIENCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Defects in lymphocyte numbers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - T cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Regulatory T cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - B cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Defects in T cell function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Hyper IgM syndrome (HIGM)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Autoimmune lymphoproliferative syndrome (ALPS)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Hyper-immunoglobulin E syndrome (HIES)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7730509\">",
"      - X-linked lymphoproliferative (XLP) syndrome and X-linked inhibitor of apoptosis (XIAP) deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7730525\">",
"      - Wiskott-Aldrich syndrome (WAS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Defects in B cell function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Common Variable Immunodeficiency (CVID)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cytotoxic lymphocyte defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cytotoxicity assays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Expression of cytotoxic molecules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Innate immune system defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Leukocyte adhesion deficiencies (LAD)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Chronic granulomatous disease (CGD)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Toll-like receptor (TLR) defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3937\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3937|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/31/28147\" title=\"figure 1\">",
"      Flow cytometry basics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/47/32501\" title=\"figure 2\">",
"      Periph blood anal I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/31/11763\" title=\"figure 3\">",
"      Periph blood anal II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/37/35412\" title=\"figure 4\">",
"      Lymphocyte subset anal I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/5/28753\" title=\"figure 5\">",
"      Lymphocyte subset anal II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/19/17713\" title=\"figure 6\">",
"      Periph blood Tregs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/61/36820\" title=\"figure 7\">",
"      BTK expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/17/16657\" title=\"figure 8\">",
"      CD40L CD40 expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/43/18100\" title=\"figure 9\">",
"      Dbl neg T cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/49/30495\" title=\"figure 10\">",
"      IL17a expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/38/18016\" title=\"figure 11\">",
"      Flow cytometry for XLP and XIAP deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/51/4916\" title=\"figure 12\">",
"      B cell anal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/21/13648\" title=\"figure 13\">",
"      Flow cytometric analysis for WAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/27/36280\" title=\"figure 14\">",
"      Cytotoxicity assays I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/59/6065\" title=\"figure 15\">",
"      Cytotoxicity assays II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/40/33408\" title=\"figure 16\">",
"      Cytotoxicity assays III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/48/28431\" title=\"figure 17\">",
"      Adhesion mol anal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/18/32032\" title=\"figure 18\">",
"      DHR assay",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/35/29237\" title=\"figure 19\">",
"      Flow cytometric analysis for MSMD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/36/27200\" title=\"figure 20\">",
"      TLR pathway anal",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=related_link\">",
"      Agammaglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5735?source=related_link\">",
"      Apoptosis and autoimmune disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10826?source=related_link\">",
"      Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=related_link\">",
"      Combined immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=related_link\">",
"      Hemophagocytic lymphohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32153?source=related_link\">",
"      Hyperimmunoglobulin E syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25850?source=related_link\">",
"      IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22953?source=related_link\">",
"      Leukocyte adhesion deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=related_link\">",
"      Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=related_link\">",
"      NK cell deficiency syndromes: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/38/33384?source=related_link\">",
"      X-linked lymphoproliferative disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23657="Gastroesophageal reflux in premature infants";
var content_f23_6_23657=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gastroesophageal reflux in premature infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Richard Martin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Anna Maria Hibbs, MD, MSCE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23657/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/6/23657/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, occurs commonly in newborn infants, especially those born prematurely. Physiologic GER typically is a developmental process that resolves with maturation. GER generally resolves on its own by one year of age. In infants who remain asymptomatic, no further evaluation or intervention is typically required.",
"   </p>",
"   <p>",
"    In contrast, GER disease (GERD), as defined by the North American Society for Pediatric Gastroenterology and Nutrition, is clinically significant GER that causes morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/1\">",
"     1",
"    </a>",
"    ]. Putative morbidities of GERD in preterm infants include frequent vomiting, aspiration pneumonia, irritability, failure to thrive, and exacerbation of respiratory symptoms, including chronic lung disease.",
"   </p>",
"   <p>",
"    GER in preterm infants will be reviewed here. GER in infants, children, and adolescents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link\">",
"     \"Gastroesophageal reflux in infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=see_link\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux (GER) is extremely common in healthy infants in whom gastric fluids reflux into the esophagus 30 or more times daily. It appears that GER is more common in healthy preterm compared with term infants. The pathogenesis of GER in preterm infants appears to be multifactorial due in part to immature or impaired anatomic and physiologic factors that typically limit reflux.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Relaxation of lower esophageal sphincter",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important mechanism of GER in preterm infants (similar to older infants and adults) is transient relaxation of the lower esophageal sphincter (LES) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The LES is comprised of intrinsic smooth muscle of the esophagus and skeletal muscle of the crural diaphragm [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transient LES relaxation is defined as an abrupt decrease in LES pressure below the intragastric pressure, which is unrelated to swallowing and allows regurgitation of stomach contents into the esophagus. Normally, the LES relaxes with the onset of esophageal contractions triggered by swallowing as food passes down the esophagus, and contracts when swallowing ceases in order to prevent reflux by maintaining a lower esophageal pressure that is higher than the intragastric pressure.",
"   </p>",
"   <p>",
"    The frequency of transient LES relaxation is the same in preterm infants with and without GER disease (GERD). However, infants with GERD are more likely to experience acid regurgitation during LES relaxation than those without GERD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Gastric emptying",
"    </span>",
"    &nbsp;&mdash;&nbsp;The time for gastric emptying increases with decreasing gestational age. This was illustrated in a study of preterm infants born between 25 to 30 weeks gestation that demonstrated emptying time decreased linearly with advancing gestational age at birth when emptying time was measured by breath tests using isotope labeled feeds [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The delay in gastric emptying in preterm infants may provide a greater gastric volume of liquid available for reflux. However, there are no data that show a delay in gastric emptying in preterm infants with symptomatic GER compared with asymptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Esophageal motility",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the preterm infant, esophageal motility may be immature and contribute to GER [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/7\">",
"     7",
"    </a>",
"    ]. In one study that evaluated esophageal function during swallowing, increasing gestational age was correlated with increasing completion of secondary esophageal peristalsis, shortening of proximal esophageal sphincter contraction, and faster propagation velocity for liquids [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/7\">",
"     7",
"    </a>",
"    ]. Another study that utilized high-resolution manometry confirmed that preterm compared with term infants were more likely to have incomplete esophageal peristalsis during swallowing [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/8\">",
"     8",
"    </a>",
"    ]. Differences in swallow propagation during active sleep between preterm and term infants have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/9\">",
"     9",
"    </a>",
"    ]. However, there are no data showing differences in motility maturation directly correlating with an increased risk of symptomatic GER in preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Respiratory disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;GER may occur more frequently in infants who have respiratory disorders, such as bronchopulmonary dysplasia [BPD]. One possible mechanism contributing to increased reflux in infants with respiratory disorders may be that increased work of breathing results in a relative increase of intraabdominal versus intrathoracic pressures, which facilitates GER.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Gastric tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of nasogastric or orogastric tube, which is commonly used in preterm infants, may increase GER because it may cause greater LES relaxation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    decreased gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     General symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the nonspecific nature of the symptoms associated with gastroesophageal reflux disease (GERD), there is a wide variation among clinicians regarding their beliefs about the presenting signs and symptoms of GERD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/13\">",
"     13",
"    </a>",
"    ]. In general, symptoms include irritability, generalized behavioral discomfort, frequent bouts of emesis, posturing or grimacing, worsening of lung disease, and failure to thrive.",
"   </p>",
"   <p>",
"    Gastroesophageal reflux (GER) appears to be more frequent after feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/14\">",
"     14",
"    </a>",
"    ]. The reflux is less acidic and is higher in the esophagus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bronchopulmonary dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;GER has been proposed as a contributor to the pathogenesis of bronchopulmonary dysplasia (BPD) due to aspiration of gastric contents into the lungs. This causal relationship was supported by one study that demonstrated an increased pepsin concentration in the tracheal aspirates of preterm infants who develop BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/15\">",
"     15",
"    </a>",
"    ]. Another retrospective study reported an association between BPD and a diagnosis of GER among very low birth weight (VLBW) infants (birth weight &lt;1500 g) at one year adjusted age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/16\">",
"     16",
"    </a>",
"    ]. However, this finding may be biased because of the possible greater diagnostic suspicion for GERD among infants with BPD, resulting in a more thorough reflux investigation in this group of infants. In contrast, two other studies did not find an association between GER and BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Failure to thrive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to thrive is a condition often attributed to GER. In a small match-controlled retrospective study of 23 preterm infants with clinically significant GER, there were no differences in the average weekly weight gain, caloric intake, and growth parameters between patients and matched controls. However, infants with GER took longer to achieve full oral feedings (32 versus 19 days) and had a longer length of hospital stay (99 versus 70 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Relationship to apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of physiologic protective reflex responses provide a plausible biological link between GER and apnea of prematurity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/20\">",
"     20",
"    </a>",
"    ]. As an example, evidence from animal models demonstrated fluid stimulation of the laryngeal mucosa inhibited normal respiratory patterns [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is uncertain whether there is a causal association between GER and apnea of prematurity. Several studies performed in the 1970s and 1980s linked GER with apnea or respiratory arrest in neonates born at term and in older infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/22-25\">",
"     22-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, subsequent studies in preterm infants have mostly failed to demonstrate a temporal relationship between GER and apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/26-33\">",
"     26-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of a temporal relationship between these two conditions has been demonstrated in studies that utilized cardiorespiratory monitoring, including respiratory inductance plethysmography, heart rate monitoring, oxygen saturation, and esophageal pH testing to detect acidic GER [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. This was best illustrated in the largest of these studies from a single center that performed 12-hour cardiorespiratory monitoring in 119 premature infants with a mean gestational age of 28 weeks that resulted in 6255 recorded GER episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/30\">",
"     30",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apnea &ge;15 seconds was associated with only 1 percent of the GER episodes. There was no difference in the rate of apnea &ge;15 seconds before, during, or after GER episodes.",
"     </li>",
"     <li>",
"      Apnea &ge;10 seconds was associated with 8.5 percent of the GER episodes. There was no difference in the rate of apnea &ge;10 seconds before or during GER episodes, but the rate decreased immediately after GER episodes.",
"     </li>",
"     <li>",
"      There was no difference between the mean duration of apnea before or during GER episodes (12.3 versus 13.9 seconds).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a subsequent study from the same tertiary center, less than 3 percent of all cardiorespiratory events (defined as apnea &ge;10 seconds in duration, bradycardia &le;80 beats per minute, and oxygen desaturation &le;85 percent) were preceded by GER [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/34\">",
"     34",
"    </a>",
"    ]. In patients with associated GER, there was no increase in the duration of the event or severity.",
"   </p>",
"   <p>",
"    Studies using multiple intraluminal impedance to detect nonacidic GER also demonstrated similar findings and failed to show a causal association of GER to apnea in preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. These data show that GER and apnea do occur in the same infant but generally as two separate events.",
"   </p>",
"   <p>",
"    In a follow-up report of premature infants, motility studies in premature infants (postmenstrual age range from 34 to 37 weeks) demonstrated that apneic episodes were associated with a reduction in LES tone [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/35\">",
"     35",
"    </a>",
"    ]. Similar results have been reported in a study of newborn piglets [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/36\">",
"     36",
"    </a>",
"    ]. These findings suggest that apnea may precipitate GER rather than the opposite relationship of GER causing apnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of gastroesophageal reflux (GER) is challenging in preterm infants because, as previously mentioned, symptoms are nonspecific, and diagnostic testing is limited due to technical problems and difficulties of interpreting results in the newborn.",
"   </p>",
"   <p>",
"    In addition, the postconceptional age at which preterm infants can safely undergo procedures may be a limiting factor for diagnostic testing. Small, medically unstable infants may not be able to tolerate being transported for radiologic testing, or placement of a pH or multiple intraluminal impedance probe in the nostril, because it may compromise respiratory status or increase the risk of esophageal perforation from probe placement in the smallest infants, although this has not been reported in the literature. The size at which the diagnostic procedures may be safely accomplished will depend on institutional comfort and familiarity. In our institution, for instance, we rarely place a multiple intraluminal impedance probe, which is stiffer than a pH probe, in infants with a weight less than 1600 g.",
"   </p>",
"   <p>",
"    Thus, many clinicians use a therapeutic trial in infants in whom GER is suspected based upon the history and physical examination without performing an extensive diagnostic evaluation if testing is not available or if there is a concern that the infant safety may be compromised by attempting a diagnostic procedure. However, nonpharmacologic management should be the mainstay of therapy in the most immature and vulnerable patients who are at greatest risk for adverse events from procedures and pharmacologic therapy (",
"    <a class=\"graphic graphic_algorithm graphicRef80054 \" href=\"UTD.htm?8/38/8815\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     History and examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nonspecific signs associated with GER include regurgitation of milk, vomiting, irritability, arching, grimacing, desaturation, and respiratory symptoms. In contrast, bilious vomiting, gastrointestinal bleeding, diarrhea, constipation, fever, lethargy, abdominal tenderness and distension, and hepatosplenomegaly suggest another diagnosis other than GER [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the premature infants, diagnostic testing includes esophageal pH probe and multiple intraluminal impedance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Esophageal pH probe",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal pH measurement to detect reflux of acidic gastric contents in the distal esophagus is the most widely employed diagnostic test for GER in preterm infants. The test, which may last up to 24 hours, is performed by the transnasal passage of a microelectrode containing a pH sensor into the lower third of the esophagus. The wide spectrum of size of preterm infants makes placement of the catheter challenging. However, placement is crucial, as misplacement may result in under- or overestimation of acid reflux, especially in the smallest infants in whom a small error in positioning could give rise to a potentially large error in the results [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/38\">",
"     38",
"    </a>",
"    ]. The catheter is placed using the Strobel formula that correlates the patient's length to",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    esophageal length [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/39\">",
"     39",
"    </a>",
"    ]. Placement is confirmed radiographically.",
"   </p>",
"   <p>",
"    Various scoring techniques have been used to interpret the results of pH probe studies, and generally include the number of acid reflux episodes, average duration of the episodes, and overall proportion of time with a pH less than four. The reflux index (RI), which consists of the sum of the periods in which pH is less than four as a percent of recording time, is a widely used scoring system. Data from term infants referred for screening for an increased risk of sudden infant death syndrome reported that the 95th percentile for RI was about 10 percent, and the 50th percentile was in the 4 to 5 percent range [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/40\">",
"     40",
"    </a>",
"    ]. It is important to note that acid may not be detected postprandially in infants because milk will buffer acid contained in the refluxate, leading to underestimation of GER.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Intraluminal impedance",
"    </span>",
"    &nbsp;&mdash;&nbsp;This newer technique, also known as multiple intraluminal impedance (MII), uses an esophageal catheter designed to measure impedance from multiple intraluminal recording sensors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/41\">",
"     41",
"    </a>",
"    ]. The method allows detection of GER based on changes in electrical resistance to electrical current flow between two electrodes when a liquid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gas bolus moves between them. Impedance detects GER if there is a sequential drop in impedance to less than 50 percent of baseline values, starting distally above the lower esophageal sphincter and propagating retrograde to at least the next two more proximal measuring segments. Therefore, anterograde swallows can be differentiated from retrograde boluses (GER). This emerging technology is being employed as both a clinical and research tool in preterm infants.",
"   </p>",
"   <p>",
"    The obvious advantage of MII is the ability to assess postprandial reflux, which may be masked by milk neutralizing the acid content of the refluxant when only a pH probe is used. This was illustrated in one study of preterm infants (gestational age of 23 to 37 weeks, tested at a postconceptional age between 34 to 48 weeks) that showed more episodes of reflux and less acidic reflux contents after versus before a feed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, several reservations associated with the use of MII in preterm infants remain, particularly the lack of validated normative standards in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. When compared to pH measurement, MII detects more frequent and shorter duration episodes, which are of uncertain clinical significance. Finally, it is important not to measure impedance based reflux alone, as there is a high incidence of acid reflux events detected by pH monitoring that is not identified by MII [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/44\">",
"     44",
"    </a>",
"    ]. Acid reflux events missed by MII occurred most often in the least mature infants, possibly due to delayed esophageal fluid clearance in this immature population. To address this issue, MII has been combined with esophageal pH into a single probe [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/42,45\">",
"     42,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Other techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Techniques used to detect GER in older infants and children, including endoscopy and esophageal manometry, are rarely employed in neonates because of size limitation. The need to perform biopsy to diagnose esophagitis is almost nonexistent.",
"   </p>",
"   <p>",
"    Other studies that may be performed in neonates include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Upper gastrointestinal series &mdash; An upper gastrointestinal (UGI) series with small bowel follow-through should be performed in infants with severe GER. This study is used to evaluate esophageal, gastric, and intestinal anatomy because congenital anomalies in these structures may cause reflux or vomiting.",
"      <br/>",
"      <br/>",
"      However, UGI is a poor method to demonstrate GER, because the procedure is performed under nonphysiologic conditions that may provoke reflux that is not clinically important. Also, a UGI may not detect clinically significant GER because the period of fluoroscopic monitoring is brief, typically less than five minutes.",
"     </li>",
"     <li>",
"      Technetium scintigraphy &mdash; A nuclear medicine scintigraphy study, often commonly referred to as a milk scan, allows detection of esophageal reflux events, measurement of gastric emptying time, and detection of aspirated gastric contents in the lungs. However, this technique is more likely to miss reflux events than continuous pH or MII monitoring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial treatment for gastroesophageal reflux (GER) is conservative and consists of dietary changes and parental education [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/46\">",
"     46",
"    </a>",
"    ]. Pharmacologic therapy is reserved for infants who fail conservative management and have excessive reflux demonstrated on diagnostic testing (",
"    <a class=\"graphic graphic_algorithm graphicRef80054 \" href=\"UTD.htm?8/38/8815\">",
"     algorithm 1",
"    </a>",
"    ). As discussed previously, diagnostic testing is difficult to perform in preterm infants, and a therapeutic time-limited trial often is used in patients suspected of having significant GER when testing is not feasible. The need for intervention should be reassessed every two to three weeks as maturation occurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;About half of all infants between zero and four months of age regurgitate at least once per day, with symptoms peaking at four months of age when the majority of infants have clinical GER. As a result, the North American Society for Pediatric Gastroenterology and Nutrition generally recommends that \"happy spitters\" without any morbidity should not be treated for GER disease (GERD) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/1\">",
"     1",
"    </a>",
"    ]. However, these recommendations do not specifically address preterm infants in whom it is often difficult to distinguish between GER and GERD, especially when deciding to initiate treatment and evaluate the efficacy of different therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link&amp;anchor=H4#H4\">",
"     \"Gastroesophageal reflux in infants\", section on 'Natural history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of the nonspecific symptoms associated with GERD, the indications used among clinicians to initiate therapy in preterm infants vary. In our practice, we initiate GER treatment for GER when there are significant symptoms and concern for harmful sequelae by initially starting with nonpharmacologic interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Nonpharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial nonpharmacologic therapy includes dietary changes and parental education [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/46\">",
"     46",
"    </a>",
"    ]. We assure the parents that reflux is a common physiologic occurrence in preterm infants that will resolve on its own and generally does not need significant intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;In term and older infants with presumed symptomatic GER, several dietary manipulations have been investigated, including smaller more frequent feeds, thickened feeds, and a trial of cow-milk free diet. However, these dietary modifications have not been adequately studied in preterm infants with GERD. In particular, the use of feeds thickened by rice cereal may be challenging in preterm infants with weak oromotor skills or who are fed by tube-feeds. In addition, it remains unclear whether this dietary manipulation is effective in preterm infants, as the available limited data report conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link&amp;anchor=H20#H20\">",
"     \"Gastroesophageal reflux in infants\", section on 'Lifestyle changes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of the commercial thickener, SimplyThick, should not be used in preterm infants because of a possible link with necrotizing enterocolitis (NEC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. In June 2011, the Food and Drug Administration published a warning not to use this product because of the possible concern of NEC (",
"    <a class=\"external\" href=\"file://www.fda.gov/NewsEvents/newsroom/PressAnnouncements/ucm256253.htm\">",
"     FDA warning about Simply Thick",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Position",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal feeding and postprandial positions for premature infants remain uncertain despite extensive study, as demonstrated by the following discussion. In addition, the prone sleeping position is associated with an increased risk of sudden infant death syndrome (SIDS). Because there is no evidence of a preferred position to reduce GER, it is important to model supine positioning prior to discharge in the hospital and to educate families to use the supine sleeping position at home. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37194?source=see_link\">",
"     \"Sudden infant death syndrome: Risk factors and risk reduction strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following studies, which evaluated the effect of body positioning on GER in premature infants using a combination of pH and electrical impedance monitoring, failed to identify a preferred position to reduce the risk of GER.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prone versus supine positioning",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a study of 22 symptomatic premature infants (ie, frequent episodes of regurgitation and postprandial desaturation) with a median gestational age of 31 weeks (range 24 to 32 weeks) and birth weight of 1220 g (range 630 to 2250), prone position at median postmenstrual age of 36 weeks (range 33 to 38 weeks) was associated with the fewest number of acidic and nonacidic GER episodes (4.4 and 0.3 percent) followed by left lateral positioning (7.5 and 0.7), supine (17.6 and 1.3 percent), and right lateral positioning (21.4 and 1.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 21 premature infants at a median postmenstrual age of 36 weeks, although acid reflux index and obstructive apnea episodes were higher in the supine compared with the prone position, there were no clinically important differences in either parameter between the two positions [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Right versus left lateral positioning",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A study of 10 healthy asymptomatic premature infants with a median gestational age of 31 weeks (range 27 to 36 weeks) were evaluated at a median postmenstrual age of 36 weeks (range 33 to 38 weeks) either in the right or left lateral position during gavage feeds, which was changed to the opposite after one hour [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/53\">",
"       53",
"      </a>",
"      ]. Although the frequency of GER episodes, primarily liquid GER, was greater with initial right compared with left lateral positioning, gastric emptying time was shorter with initial right side positioning. This resulted in a greatly reduced rate of liquid reflux during the second postprandial hour (when acidity of the reflux is increasing) with the initial right versus left lateral positioning.",
"     </li>",
"     <li>",
"      In a study of eight healthy preterm infants (mean 36.1 weeks post menstrual age), more episodes of lower esophageal sphincter relaxation (LESR) and GER occurred when infants were placed in a right versus left lateral position [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/54\">",
"       54",
"      </a>",
"      ]. In addition, LESR was triggered by lower continuously infused feeding volumes in the right versus left lateral position.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elevation of the head &mdash; Studies in term and older infants demonstrate that elevation of the head is not beneficial in reducing GER [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Available data do not identify a preferred position to reduce GER that outweighs the recommendation for supine position and that also reduces the risk of SIDS. As a result, preterm infants should be placed in the supine position for sleep even if they have reflux.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In premature infants with GER, antireflux therapies are among the most commonly prescribed drugs in the neonatal intensive care unit (NICU) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/56\">",
"     56",
"    </a>",
"    ]. This was illustrated by a report from the National Institute of Child Health and Human Development Neonatal Research Network that demonstrated 25 percent of extremely low birth weight (ELBW) infants (birth weight below 1000 g) were discharged from the hospital on antireflux medications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therapy consists of two different approaches.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acid suppression agents increase gastric pH, and thereby reduce esophageal acid exposure during episodes of reflux. They include histamine 2 (H2) receptor antagonists (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/61/29655?source=see_link\">",
"       famotidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/1/33815?source=see_link\">",
"       ranitidine",
"      </a>",
"      , or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/62/38885?source=see_link\">",
"       nizatidine",
"      </a>",
"      ) and proton pump inhibitors (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"       omeprazole",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/53/2904?source=see_link\">",
"       lansoprazole",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Prokinetic agents improve gastric emptying",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      esophageal sphincter tone, and include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"       metoclopramide",
"      </a>",
"      or cisapride. These agents do not reduce the occurrence of transient lower esophageal relaxations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Acid suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acid suppression therapy is widely used in neonatal practice with little evidence of short- or long-term benefit.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      H2 receptor antagonists, such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/1/33815?source=see_link\">",
"       ranitidine",
"      </a>",
"      , limit the action of histamine released from mast cells. Although the pharmacokinetics of ranitidine have been studied in the preterm infant, efficacy for relief of GERD in this population has not been demonstrated. It is logical to assume that reduction of gastric pH would be useful therapy for esophagitis, but this entity is not reliably diagnosed by symptoms alone in infants.",
"     </li>",
"     <li>",
"      Proton pump inhibitors (PPIs), such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"       omeprazole",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/53/2904?source=see_link\">",
"       lansoprazole",
"      </a>",
"      , have become increasingly popular for GERD therapy because of their superior acid-reducing effect during short- and long-term therapy. PPIs act by irreversibly inhibiting",
"      <span class=\"nowrap\">",
"       H+/K+-ATPase",
"      </span>",
"      in the parietal cell. The number of infants on PPIs in the US has dramatically increased in the last several years, and 49 percent of infants on PPIs are started in the first four months of life [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Limited data have shown that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"     omeprazole",
"    </a>",
"    compared with placebo reduces gastric acidity and the duration of acid exposure in preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/60\">",
"     60",
"    </a>",
"    ]. A small study of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/38/21095?source=see_link\">",
"     esomeprazole",
"    </a>",
"    showed a decrease in acidity, but not in the frequency, extent, or clearance of esophageal boluses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, symptoms, and not physiological measures, define the difference between GER and GERD. A double-blinded randomized multicenter trial of infants demonstrated no difference in the reduction of symptoms attributed to GER between",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/53/2904?source=see_link\">",
"     lansoprazole",
"    </a>",
"    compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/62\">",
"     62",
"    </a>",
"    ]. There were more serious adverse effects, particularly lower respiratory tract infections, in the lansoprazole group. Although 44 of the 162 infants were preterm, a subset analysis was not performed due to the small number of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link&amp;anchor=H25#H25\">",
"     \"Gastroesophageal reflux in infants\", section on 'Pharmacotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, potential adverse effects of the medications raise safety concerns as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastric acid suppression has been linked to necrotizing enterocolitis and altered gastric colonization in the NICU, and in some studies, increased risk of sepsis, pneumonia, and other infections [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/62-66\">",
"       62-66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"       cimetidine",
"      </a>",
"      in very low birth weight (VLBW) infants was stopped by the safety monitoring committee because of increased death or severe intraventricular hemorrhage in the cimetidine group [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/67\">",
"       67",
"      </a>",
"      ]. Although this study hypothesis was about reducing oxidative injury in the lung, not GER, it is a cautionary tale in the use of unproven therapies in preterm infants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Prokinetic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of prokinetic agents has been limited in preterm infants because of the uncertainty of benefit and the potential for significant adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/68-73\">",
"     68-73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The efficacy of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"       metoclopramide",
"      </a>",
"      remains uncertain, and it has several reported adverse effects including irritability, rare dystonic reactions, and extrapyramidal symptoms in infants [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/68,69\">",
"       68,69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cisapride was removed from the market in Canada and the United States because of the risk of ventricular arrhythmia [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/72,73\">",
"       72,73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/44/7878?source=see_link\">",
"       Baclofen",
"      </a>",
"      , a gamma-amino-butyric acid B receptor agonist, promotes gastric emptying in children with GERD [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/71\">",
"       71",
"      </a>",
"      ], but its safety and efficacy in preterm infants is not sufficiently established to warrant routine use in this population.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/11/38064?source=see_link\">",
"       Erythromycin",
"      </a>",
"      does not decrease feeding intolerance, as shown by a meta-analysis of 10 randomized trials that demonstrated no benefit of erythromycin as a prokinetic agent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These agents are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Prokinetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A small trial in preterm infants with a mean gestational age of 29 weeks found that a combined regimen of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/47/759?source=see_link\">",
"     metoclopramide",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/1/33815?source=see_link\">",
"     ranitidine",
"    </a>",
"    compared with placebo did not reduce, and may have increased, the episodes of bradycardia attributed to GER [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/74\">",
"     74",
"    </a>",
"    ]. An important additional result was the observation that there was a decrease in the frequency of bradycardia episodes over time, which was unrelated to treatment. This may contribute to misleading conclusions in nonrandomized and unmasked trials, which do not take this finding into account.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Transpyloric feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transpyloric placement of an enteral feeding tube in the duodenum or jejunum has the theoretical advantage of decreasing GER. However, there are technical challenges associated with correct tube placement and maintenance of position, as well as bypassing the gastric phase of digestion. A meta-analysis of this technique failed to find any advantage with respect to growth or time to establish full oral feeds, and reported an increased incidence of gastrointestinal disturbance and possibly mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23657/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical intervention is reserved for infants with severe GERD who have failed aggressive medical management. These patients often have major central nervous system and respiratory morbidity, or have suffered a life-threatening event associated with reflux. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=see_link&amp;anchor=H12#H12\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/24/43394?source=see_link\">",
"       \"Patient information: Acid reflux (gastroesophageal reflux) in babies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastroesophageal reflux (GER) is common during infancy, especially in preterm infants. The increased risk of GER in preterm infants is thought to be due to immature or impaired anatomic and physiologic factors that typically limit reflux. Most infants remain asymptomatic from their GER and do not require further evaluation or intervention, as GER will resolve on its own by one year of age. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanisms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      GER disease (GERD) is defined as GER that causes morbidity. Symptoms associated with GERD are generally nonspecific in preterm infants, and are thought to include irritability, generalized behavioral discomfort, posturing, grimacing, emesis, worsening of lung disease, and failure to thrive; however, definitive evidence for these associations is lacking. In particular, there is a paucity of evidence for a relationship between GERD and apnea of prematurity. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of GER is challenging in preterm infants because symptoms are nonspecific, and diagnostic testing is limited due to technical problems and difficulties of interpreting results in the newborn. Many clinicians use a time-limited therapeutic trial in infants in whom GER is suspected based upon the history and physical examination without preforming an extensive diagnostic evaluation. When feasible, diagnostic testing should be considered before the initiation of pharmacologic therapy in preterm infants. The most common diagnostic test performed in preterm infants is esophageal pH monitoring. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment should be reserved for infants in whom there is concern for reflux causing harmful sequelae (",
"      <a class=\"graphic graphic_algorithm graphicRef80054 \" href=\"UTD.htm?8/38/8815\">",
"       algorithm 1",
"      </a>",
"      ). Management initially is begun with nonpharmacologic measures that include dietary changes (eg, smaller frequent feeds, and thickened feeds using rice cereal) based upon evidence from term and older infants and parental education. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Nonpharmacologic therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link&amp;anchor=H20#H20\">",
"       \"Gastroesophageal reflux in infants\", section on 'Lifestyle changes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pharmacologic therapy that has been used in preterm infants includes histamine H2 receptor antagonists, proton pump inhibitors, and prokinetic agents. They have not been definitively shown to be effective in improving symptoms and may be associated with adverse sequelae, and so should be reserved for infants with significant disease who fail nonpharmacologic measures. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Pharmacologic therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/1\">",
"      Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32 Suppl 2:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/2\">",
"      Omari TI, Barnett C, Snel A, et al. Mechanisms of gastroesophageal reflux in healthy premature infants. J Pediatr 1998; 133:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/3\">",
"      Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 2002; 51:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/4\">",
"      Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997; 336:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/5\">",
"      Davidson G. The role of lower esophageal sphincter function and dysmotility in gastroesophageal reflux in premature infants and in the first year of life. J Pediatr Gastroenterol Nutr 2003; 37 Suppl 1:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/6\">",
"      Ramirez A, Wong WW, Shulman RJ. Factors regulating gastric emptying in preterm infants. J Pediatr 2006; 149:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/7\">",
"      Jadcherla SR, Duong HQ, Hoffmann RG, Shaker R. Esophageal body and upper esophageal sphincter motor responses to esophageal provocation during maturation in preterm newborns. J Pediatr 2003; 143:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/8\">",
"      Staiano A, Boccia G, Salvia G, et al. Development of esophageal peristalsis in preterm and term neonates. Gastroenterology 2007; 132:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/9\">",
"      Jeffery HE, Ius D, Page M. The role of swallowing during active sleep in the clearance of reflux in term and preterm infants. J Pediatr 2000; 137:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/10\">",
"      Omari TI, Benninga MA, Barnett CP, et al. Characterization of esophageal body and lower esophageal sphincter motor function in the very premature neonate. J Pediatr 1999; 135:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/11\">",
"      Peter CS, Wiechers C, Bohnhorst B, et al. Influence of nasogastric tubes on gastroesophageal reflux in preterm infants: a multiple intraluminal impedance study. J Pediatr 2002; 141:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/12\">",
"      Mendes TB, Mezzacappa MA, Toro AA, Ribeiro JD. Risk factors for gastroesophageal reflux disease in very low birth weight infants with bronchopulmonary dysplasia. J Pediatr (Rio J) 2008; 84:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/13\">",
"      Golski CA, Rome ES, Martin RJ, et al. Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants. Pediatrics 2010; 125:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/14\">",
"      Slocum C, Arko M, Di Fiore J, et al. Apnea, bradycardia and desaturation in preterm infants before and after feeding. J Perinatol 2009; 29:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/15\">",
"      Farhath S, He Z, Nakhla T, et al. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics 2008; 121:e253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/16\">",
"      Fuloria M, Hiatt D, Dillard RG, O'Shea TM. Gastroesophageal reflux in very low birth weight infants: association with chronic lung disease and outcomes through 1 year of age. J Perinatol 2000; 20:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/17\">",
"      Khalaf MN, Porat R, Brodsky NL, Bhandari V. Clinical correlations in infants in the neonatal intensive care unit with varying severity of gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2001; 32:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/18\">",
"      Akinola E, Rosenkrantz TS, Pappagallo M, et al. Gastroesophageal reflux in infants &lt; 32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol 2004; 21:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/19\">",
"      Frakaloss G, Burke G, Sanders MR. Impact of gastroesophageal reflux on growth and hospital stay in premature infants. J Pediatr Gastroenterol Nutr 1998; 26:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/20\">",
"      Slocum C, Hibbs AM, Martin RJ, Orenstein SR. Infant apnea and gastroesophageal reflux: a critical review and framework for further investigation. Curr Gastroenterol Rep 2007; 9:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/21\">",
"      St-Hilaire M, Nsegbe E, Gagnon-Gervais K, et al. Laryngeal chemoreflexes induced by acid, water, and saline in nonsedated newborn lambs during quiet sleep. J Appl Physiol 2005; 98:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/22\">",
"      Leape LL, Holder TM, Franklin JD, et al. Respiratory arrest in infants secondary to gastroesophageal reflux. Pediatrics 1977; 60:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/23\">",
"      Herbst JJ, Book LS, Bray PF. Gastroesophageal reflux in the \"near miss\" sudden infant death syndrome. J Pediatr 1978; 92:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/24\">",
"      Spitzer AR, Boyle JT, Tuchman DN, Fox WW. Awake apnea associated with gastroesophageal reflux: a specific clinical syndrome. J Pediatr 1984; 104:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/25\">",
"      Herbst JJ, Minton SD, Book LS. Gastroesophageal reflux causing respiratory distress and apnea in newborn infants. J Pediatr 1979; 95:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/26\">",
"      Molloy EJ, Di Fiore JM, Martin RJ. Does gastroesophageal reflux cause apnea in preterm infants? Biol Neonate 2005; 87:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/27\">",
"      Barrington KJ, Tan K, Rich W. Apnea at discharge and gastro-esophageal reflux in the preterm infant. J Perinatol 2002; 22:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/28\">",
"      Paton JY, Macfadyen U, Williams A, Simpson H. Gastro-oesophageal reflux and apnoeic pauses during sleep in infancy--no direct relation. Eur J Pediatr 1990; 149:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/29\">",
"      de Ajuriaguerra M, Radvanyi-Bouvet MF, Huon C, Moriette G. Gastroesophageal reflux and apnea in prematurely born infants during wakefulness and sleep. Am J Dis Child 1991; 145:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/30\">",
"      Di Fiore JM, Arko M, Whitehouse M, et al. Apnea is not prolonged by acid gastroesophageal reflux in preterm infants. Pediatrics 2005; 116:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/31\">",
"      Peter CS, Sprodowski N, Bohnhorst B, et al. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics 2002; 109:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/32\">",
"      Mousa H, Woodley FW, Metheney M, Hayes J. Testing the association between gastroesophageal reflux and apnea in infants. J Pediatr Gastroenterol Nutr 2005; 41:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/33\">",
"      Corvaglia L, Zama D, Gualdi S, et al. Gastro-oesophageal reflux increases the number of apnoeas in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94:F188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/34\">",
"      Di Fiore J, Arko M, Herynk B, et al. Characterization of cardiorespiratory events following gastroesophageal reflux in preterm infants. J Perinatol 2010; 30:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/35\">",
"      Omari TI. Apnea-associated reduction in lower esophageal sphincter tone in premature infants. J Pediatr 2009; 154:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/36\">",
"      Kiatchoosakun P, Dreshaj IA, Abu-Shaweesh JM, et al. Effects of hypoxia on respiratory neural output and lower esophageal sphincter pressure in piglets. Pediatr Res 2002; 52:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/37\">",
"      Tipnis NA, Tipnis SM. Controversies in the treatment of gastroesophageal reflux disease in preterm infants. Clin Perinatol 2009; 36:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/38\">",
"      Emmerson AJ, Chant T, May J, Vales P. Assessment of three methods of pH probe positioning in preterm infants. J Pediatr Gastroenterol Nutr 2002; 35:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/39\">",
"      Strobel CT, Byrne WJ, Ament ME, Euler AR. Correlation of esophageal lengths in children with height: application to the Tuttle test without prior esophageal manometry. J Pediatr 1979; 94:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/40\">",
"      Vandenplas Y, Goyvaerts H, Helven R, Sacre L. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/41\">",
"      Vandenplas Y, Salvatore S, Devreker T, Hauser B. Gastro-oesophageal reflux disease: oesophageal impedance versus pH monitoring. Acta Paediatr 2007; 96:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/42\">",
"      L&oacute;pez-Alonso M, Moya MJ, Cabo JA, et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 2006; 118:e299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/43\">",
"      Rosen R, Lord C, Nurko S. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin Gastroenterol Hepatol 2006; 4:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/44\">",
"      Di Fiore JM, Arko M, Churbock K, et al. Technical limitations in detection of gastroesophageal reflux in neonates. J Pediatr Gastroenterol Nutr 2009; 49:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/45\">",
"      Condino AA, Sondheimer J, Pan Z, et al. Evaluation of infantile acid and nonacid gastroesophageal reflux using combined pH monitoring and impedance measurement. J Pediatr Gastroenterol Nutr 2006; 42:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/46\">",
"      Orenstein SR, McGowan JD. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux. J Pediatr 2008; 152:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/47\">",
"      Wenzl TG, Schneider S, Scheele F, et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Pediatrics 2003; 111:e355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/48\">",
"      Corvaglia L, Ferlini M, Rotatori R, et al. Starch thickening of human milk is ineffective in reducing the gastroesophageal reflux in preterm infants: a crossover study using intraluminal impedance. J Pediatr 2006; 148:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/49\">",
"      Woods CW, Oliver T, Lewis K, Yang Q. Development of necrotizing enterocolitis in premature infants receiving thickened feeds using SimplyThick&reg;. J Perinatol 2012; 32:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/50\">",
"      Beal J, Silverman B, Bellant J, et al. Late onset necrotizing enterocolitis in infants following use of a xanthan gum-containing thickening agent. J Pediatr 2012; 161:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/51\">",
"      van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr 2007; 151:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/52\">",
"      Bhat RY, Rafferty GF, Hannam S, Greenough A. Acid gastroesophageal reflux in convalescent preterm infants: effect of posture and relationship to apnea. Pediatr Res 2007; 62:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/53\">",
"      Corvaglia L, Rotatori R, Ferlini M, et al. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr 2007; 151:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/54\">",
"      van Wijk MP, Benninga MA, Davidson GP, et al. Small volumes of feed can trigger transient lower esophageal sphincter relaxation and gastroesophageal reflux in the right lateral position in infants. J Pediatr 2010; 156:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/55\">",
"      Martin RJ, Di Fiore JM, Hibbs AM. Gastroesophageal reflux in preterm infants: is positioning the answer? J Pediatr 2007; 151:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/56\">",
"      Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006; 117:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/57\">",
"      Malcolm WF, Gantz M, Martin RJ, et al. Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. Pediatrics 2008; 121:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/58\">",
"      Barron JJ, Tan H, Spalding J, et al. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr 2007; 45:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/59\">",
"      Orenstein SR, Hassall E. Infants and proton pump inhibitors: tribulations, no trials. J Pediatr Gastroenterol Nutr 2007; 45:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/60\">",
"      Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007; 44:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/61\">",
"      Omari T, Lundborg P, Sandstr&ouml;m M, et al. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. J Pediatr 2009; 155:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/62\">",
"      Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009; 154:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/63\">",
"      Cothran DS, Borowitz SM, Sutphen JL, et al. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol 1997; 17:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/64\">",
"      Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117:e137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/65\">",
"      Carrion V, Egan EA. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1990; 11:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/66\">",
"      Terrin G, Passariello A, De Curtis M, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012; 129:e40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/67\">",
"      Cotton RB, Hazinski TA, Morrow JD, et al. Cimetidine does not prevent lung injury in newborn premature infants. Pediatr Res 2006; 59:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/68\">",
"      Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics 2006; 118:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/69\">",
"      Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnea in premature infants. J Pediatr 2001; 138:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/70\">",
"      Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev 2008; :CD001815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/71\">",
"      Omari TI, Benninga MA, Sansom L, et al. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial. J Pediatr 2006; 149:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/72\">",
"      Khoshoo V, Edell D, Clarke R. Effect of cisapride on the QT interval in infants with gastroesophageal reflux. Pediatrics 2000; 105:E24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/73\">",
"      Benatar A, Feenstra A, Decraene T, Vandenplas Y. Effects of cisapride on corrected QT interval, heart rate, and rhythm in infants undergoing polysomnography. Pediatrics 2000; 106:E85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/74\">",
"      Wheatley E, Kennedy KA. Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants. J Pediatr 2009; 155:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23657/abstract/75\">",
"      McGuire W, McEwan P. Transpyloric versus gastric tube feeding for preterm infants. Cochrane Database Syst Rev 2007; :CD003487.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4961 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-115.25.216.6-89DD65BA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23657=[""].join("\n");
var outline_f23_6_23657=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Relaxation of lower esophageal sphincter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Esophageal motility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Respiratory disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Gastric tube",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      General symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Failure to thrive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Relationship to apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      History and examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Esophageal pH probe",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Intraluminal impedance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Other techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Nonpharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Diet",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Acid suppression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Prokinetic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Transpyloric feeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4961\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4961|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?8/38/8815\" title=\"algorithm 1\">",
"      Eval GERD preterm infant",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=related_link\">",
"      Gastroesophageal reflux in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/33/19994?source=related_link\">",
"      Management of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/24/43394?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux) in babies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37194?source=related_link\">",
"      Sudden infant death syndrome: Risk factors and risk reduction strategies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23658="Jerk nystagmus";
var content_f23_6_23658=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Jerk nystagmus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Jason JS Barton, MD, PhD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/6/23658/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/6/23658/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jerk nystagmus is a rhythmic eye oscillation characterized by a slow drift of the eyes in one direction that is repeatedly corrected by fast movements in the reverse direction. In most cases the slow drift is the problem, of which there are two main causes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A tonic imbalance in a \"slow eye movement\" system, such as the vestibular or pursuit systems. This is most often due to an acute asymmetry in vestibular activity, either peripheral or central. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34165?source=see_link\">",
"       \"Overview of nystagmus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An inability to hold an eccentric eye position against the normal viscoelastic forces that tend to bring the eye back to midline (\"gaze-holding\").",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In both types, corrective fast eye movements restore the eye to its desired position. These quick or fast phases are likely generated through the same brainstem structures that create saccades.",
"   </p>",
"   <p>",
"    Jerk nystagmus is subdivided by trajectory and the conditions under which it occurs (",
"    <a class=\"graphic graphic_table graphicRef72446 \" href=\"UTD.htm?10/40/10892\">",
"     table 1",
"    </a>",
"    ). Some forms are always present, even when the eyes are in the primary position. Nystagmus in the primary position is classified according to trajectory: downbeat; upbeat; horizontal; torsional; or mixed. The direction named is the direction of the fast phase. Other forms emerge only under specific conditions such as peripheral gaze (gaze-evoked) and certain head positions (positional).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRIMARY POSITION JERK NYSTAGMUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nystagmus in the primary position is classified according to trajectory: downbeat, upbeat, horizontal, torsional, or mixed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Downbeat nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Downbeat nystagmus results from damage to one of two sites:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dorsal medulla &mdash; This interrupts pathways from both posterior semicircular canals in the floor of the fourth ventricle. The loss of tonic downward vestibular input causes the eyes to drift slowly upward.",
"     </li>",
"     <li>",
"      Cerebellar flocculus or its projections &mdash; This removes a tonic inhibition of upward vestibular eye movements [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1\">",
"       1",
"      </a>",
"      ], leading to a similar imbalance of",
"      <span class=\"nowrap\">",
"       down/up",
"      </span>",
"      vestibular impulses. This imbalance is thought to reflect a preponderance of downward \"on-direction\" velocity Purkinje cells in the flocculus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The four most frequent causes of downbeat nystagmus are cervico-medullary junction anomalies, cerebellar degenerations, multiple sclerosis, and vertebrobasilar infarction (",
"    <a class=\"graphic graphic_figure graphicRef72418 \" href=\"UTD.htm?3/51/3903\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Medications and alcohol are other relatively common causes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Arnold Chiari malformation is the most prominent of the developmental anomalies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3,6\">",
"       3,6",
"      </a>",
"      ]. Symptoms begin insidiously during adulthood. Basilar invagination and syringobulbia can also cause a similar picture [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/4,7,8\">",
"       4,7,8",
"      </a>",
"      ]. In the symptomatic patient, surgical decompression may improve the nystagmus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/7,9-11\">",
"       7,9-11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many hereditary and sporadic cerebellar degenerations can cause downbeat nystagmus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3-5,12\">",
"       3-5,12",
"      </a>",
"      ]. These are predominantly slowly progressive disorders starting in mid-adulthood. Among the genetically characterized autosomal dominant ataxias, downbeat nystagmus is often found during or between attacks of episodic ataxia type 2 (EA-2), which is caused by mutations in a brain-specific",
"      <span class=\"nowrap\">",
"       P/Q",
"      </span>",
"      type calcium channel gene on chromosome 19 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/13\">",
"       13",
"      </a>",
"      ]. The attacks may respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      250 to 750",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Downbeat nystagmus has also been reported with spinocerebellar ataxia (SCA) type 17 and SCA6 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. SCA6, which is due to excessive triplet-repeats in the same calcium channel gene affected in EA-2, can have paroxysmal vertigo early in its course, and thus phenotypic overlap with EA-2 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/17\">",
"     17",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) has been described in a few case series and may represent a form of spinocerebellar degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Downbeat nystagmus is associated with bilateral vestibular failure in 36 percent of cases nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/5\">",
"     5",
"    </a>",
"    ]. For video of an example, see: (",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case85/case85.html\">",
"     file://www.neuroophthalmology.ca/cases/case85/case85.html",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      can cause downbeat nystagmus, most often as a chronic effect despite normal levels [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3,8,22,23\">",
"       3,8,22,23",
"      </a>",
"      ], and rarely with acute overdose [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. There may be predisposing conditions such as hypomagnesemia [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/22\">",
"       22",
"      </a>",
"      ], cerebellar degeneration [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/23\">",
"       23",
"      </a>",
"      ], or Chiari malformation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,25\">",
"       1,25",
"      </a>",
"      ]. Nystagmus can resolve [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/22,26\">",
"       22,26",
"      </a>",
"      ] or persist [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/23,27\">",
"       23,27",
"      </a>",
"      ] after stopping lithium.",
"     </li>",
"     <li>",
"      Anticonvulsants such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/4,5,28\">",
"       4,5,28",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/4,5,29,30\">",
"       4,5,29,30",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/31\">",
"       31",
"      </a>",
"      ], and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/31/25079?source=see_link\">",
"       felbamate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/32\">",
"       32",
"      </a>",
"      ] can cause a subacute downbeat nystagmus, which resolves with decreasing the dose. There are usually other cerebellar signs of toxicity, even if serum levels are normal [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alcohol can cause downbeat nystagmus transiently with acute intoxication [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/33\">",
"       33",
"      </a>",
"      ], or chronically from cerebellar degeneration that is often evident on imaging [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/6,34,35\">",
"       6,34,35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other rare causes of downbeat nystagmus include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acquired",
"      <span class=\"nowrap\">",
"       metabolic/nutritional",
"      </span>",
"      causes &mdash; Wernicke's encephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/8,36\">",
"       8,36",
"      </a>",
"      ] and B12 deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/37\">",
"       37",
"      </a>",
"      ]. Hypomagnesemia can induce a reversible subacute cerebellar syndrome with downbeat nystagmus associated with confusion, seizures, and tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/38\">",
"       38",
"      </a>",
"      ]. This should be suspected in the setting of intestinal malabsorption.",
"     </li>",
"     <li>",
"      Toxicity from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"       amiodarone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/5\">",
"       5",
"      </a>",
"      ] or intravenous opioids [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inherited disorders of metabolism &mdash; Cherry-red spot myoclonus.",
"     </li>",
"     <li>",
"      Infectious causes &mdash; Viral encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/5,40\">",
"       5,40",
"      </a>",
"      ], herpes simplex [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/41\">",
"       41",
"      </a>",
"      ], AIDS [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/4\">",
"       4",
"      </a>",
"      ], tetanus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autoimmune conditions &mdash; Anti-glutamic acid decarboxylase antibodies can be associated with downbeat nystagmus and ataxia, sometimes with stiff-person syndrome as well [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/43-45\">",
"       43-45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neoplasms &mdash; Posterior fossa tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/4-6,8\">",
"       4-6,8",
"      </a>",
"      ] and paraneoplastic cerebellar degeneration [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3,5,8,46\">",
"       3,5,8,46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hydrocephalus &mdash; Hydrocephalus can cause a nystagmus that resolves with shunting [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Congenital &mdash; Congenital downbeat nystagmus is very rare and sometimes familial [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. Nystagmus may persist [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/48\">",
"       48",
"      </a>",
"      ] or resolve in early childhood [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/49\">",
"       49",
"      </a>",
"      ]. Walking is delayed but eventually normal.",
"      <br/>",
"      <br/>",
"      A fine, downbeat nystagmus has also been described in associated with blue-cone monochromatism, an X-linked recessive condition [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Familial &mdash; Familial positional downbeat nystagmus with cerebellar ataxia has been described, with symptoms starting in late adulthood [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/51\">",
"       51",
"      </a>",
"      ]. Another familial condition with episodes of vertical oscillopsia and interictal downbeat nystagmus starting between the ages of 40 and 65 has been described in Taiwan, with linkage to chromosome 13 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Idiopathic downbeat nystagmus occurs in approximately 25 to 40 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3,5,6,8\">",
"     3,5,6,8",
"    </a>",
"    ]. Some of these may be caused by compression of the medulla by dolichoectatic arteries that are now visible with MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/8,53\">",
"     8,53",
"    </a>",
"    ]. Surgical decompression was successful in one case [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/53\">",
"     53",
"    </a>",
"    ]. In some other idiopathic cases, voxel-based morphometric MRI studies have demonstrated focal atrophy of gray matter in the vermal and lateral cerebellar hemispheres, suggesting a neurodegenerative process [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with downbeat nystagmus present with blurred vision, oscillopsia (to-and-fro illusion of environmental motion), or gait imbalance [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/5,6,55\">",
"     5,6,55",
"    </a>",
"    ]. Other symptoms vary with the etiology. Oscillopsia is usually constant, rarely episodic. A compressive problem such as Chiari malformation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/9,56\">",
"     9,56",
"    </a>",
"    ], hydrocephalus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/57\">",
"     57",
"    </a>",
"    ], or osteophytes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/58\">",
"     58",
"    </a>",
"    ] should be suspected if oscillopsia is provoked by neck extension or rotation.",
"   </p>",
"   <p>",
"    On physical examination, downbeat nystagmus occurs in the primary gaze position and increases with down and lateral gaze [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]; rarely, it is present only in these eccentric gaze positions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,59\">",
"     1,59",
"    </a>",
"    ]. Nystagmus may increase when the patient is lying down [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3,4,10\">",
"     3,4,10",
"    </a>",
"    ] or after head-shaking [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/17\">",
"     17",
"    </a>",
"    ]. A video demonstrating primary position downbeat nystagmus is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case9/case9.html\">",
"     file://www.neuroophthalmology.ca/cases/case9/case9.html",
"    </a>",
"   </p>",
"   <p>",
"    Other eye movement signs commonly occur with downbeat nystagmus, especially poor downward smooth pursuit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,3,4,60\">",
"     1,3,4,60",
"    </a>",
"    ]. The \"floccular syndrome\" consists of downbeat nystagmus, gaze-evoked and rebound nystagmus, and abnormal horizontal smooth pursuit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Skew deviation (a misalignment of the eyes leading to diplopia) and internuclear ophthalmoplegia are less common [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,6,55,57\">",
"     1,6,55,57",
"    </a>",
"    ]. Approximately 85 percent of patients have gait ataxia, but usually there are few other findings on routine examination [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/3\">",
"     3",
"    </a>",
"    ]. However, one case series reported that many individuals with both idiopathic as well as secondary downbeat nystagmus had comorbid peripheral vestibular deficits and polyneuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history in patients with downbeat nystagmus should concentrate upon:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medications and alcohol",
"     </li>",
"     <li>",
"      Past history of transient neurologic dysfunction suggesting multiple sclerosis",
"     </li>",
"     <li>",
"      Family history of gait imbalance and incoordination",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The exam should also search for evidence of bilateral vestibular failure, with the head thrust test (",
"    <a class=\"graphic graphic_figure graphicRef52022 \" href=\"UTD.htm?17/19/17715\">",
"     figure 2",
"    </a>",
"    ), or showing that visual acuity during head motion is drastically impaired, compared to acuity when the head is still. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link&amp;anchor=H22#H22\">",
"     \"Approach to the patient with vertigo\", section on 'Other vestibular signs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should have an MRI scan, with emphasis upon the posterior fossa and sagittal sections through the craniovertebral junction. CT scans of this region are insensitive. If imaging is negative, serum B12, magnesium, and HIV serology should be obtained.",
"   </p>",
"   <p>",
"    For patients presenting acutely, a trial of IV thiamine and glucose should be given and the cerebrospinal fluid (CSF) examined. Testing for herpes simplex virus should be performed on the CSF and coverage with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    should be considered until results are known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of nystagmus must be treated if possible. There are small reports of benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/61\">",
"     61",
"    </a>",
"    ], intravenous anticholinergics [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/62\">",
"     62",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/12,63\">",
"     12,63",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/26\">",
"     26",
"    </a>",
"    ]. The current preferred treatment is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6725?source=see_link\">",
"     dalfampridine",
"    </a>",
"    (4-aminopyridine). One randomized controlled study of 17 patients showed benefit with a single dose of dalfampridine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/64\">",
"     64",
"    </a>",
"    ]. Since then, a number of other reports have reproduced benefit with either dalfampridine or 3,4-diaminopyridine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/65-68\">",
"     65-68",
"    </a>",
"    ] including both idiopathic cases and cases with cerebellar atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/69\">",
"     69",
"    </a>",
"    ]. These drugs may not improve the gait ataxia and imbalance, however [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prisms can help those whose nystagmus is significantly reduced by divergence, convergence, or upgaze [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/36\">",
"     36",
"    </a>",
"    ]. With idiopathic downbeat nystagmus, progression is slow or may not occur at all [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Upbeat nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Projections from the anterior semicircular canals, which generate upward vestibular eye movements, travel from the vestibular to ocular motor nuclei via two pathways. One involves the brachium conjunctivum of the cerebellum [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. The second goes through the medial brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/12\">",
"     12",
"    </a>",
"    ]. Hence midline lesions of the junction of the pons and medulla or pons and midbrain cause loss of this upward input, with a resulting slow downward drift and upbeat nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. In one small study of 15 patients, the most common lesion site was the medulla in eight patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75\">",
"     75",
"    </a>",
"    ]. In the medulla, the nucleus intercalates may be a key site of damage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/76,77\">",
"     76,77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of upbeat nystagmus are cerebellar degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/55,74,78,79\">",
"     55,74,78,79",
"    </a>",
"    ] and",
"    <span class=\"nowrap\">",
"     brainstem/cerebellar",
"    </span>",
"    stroke (",
"    <a class=\"graphic graphic_figure graphicRef58225 \" href=\"UTD.htm?18/40/19087\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebellar degeneration can be acquired or hereditary.",
"     </li>",
"     <li>",
"      Most strokes are infarctions of the medial medulla [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/55,80\">",
"       55,80",
"      </a>",
"      ] or paramedian pontine tegmentum [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/81\">",
"       81",
"      </a>",
"      ] Hemorrhages of the cerebellum [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/71\">",
"       71",
"      </a>",
"      ], pons [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/82\">",
"       82",
"      </a>",
"      ], or medulla [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/83\">",
"       83",
"      </a>",
"      ] also are common.",
"     </li>",
"     <li>",
"      Demyelination can cause upbeat nystagmus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72,73,81\">",
"       72,73,81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Brainstem gliomas [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74,84,85\">",
"       74,84,85",
"      </a>",
"      ] or cerebellar tumors, including astrocytoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74,86\">",
"       74,86",
"      </a>",
"      ], ependymoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72\">",
"       72",
"      </a>",
"      ], medulloblastoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"       74",
"      </a>",
"      ], metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/70\">",
"       70",
"      </a>",
"      ], and rarely pinealoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"       74",
"      </a>",
"      ], may cause upbeat nystagmus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other more unusual causes include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Infection/inflammation",
"      </span>",
"      &mdash; Viral encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74,78\">",
"       74,78",
"      </a>",
"      ] and meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/87\">",
"       87",
"      </a>",
"      ], tuberculoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72\">",
"       72",
"      </a>",
"      ], Behcet's disease [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"       74",
"      </a>",
"      ], sarcoidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autoimmune conditions &mdash; Upbeat nystagmus, epilepsy and ataxia have been described with anti-glutamic acid decarboxylase (GAD) antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/88\">",
"       88",
"      </a>",
"      ]. Upbeat nystagmus was a feature of a paraneoplastic syndrome in a patient with pancreatic cancer without identified paraneoplastic antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/89\">",
"       89",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Metabolic &mdash; Wernicke's encephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72,90,91\">",
"       72,90,91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Toxic &mdash; Anticonvulsants [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"       74",
"      </a>",
"      ], opiates [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/92\">",
"       92",
"      </a>",
"      ], anticholinesterase insecticides [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hydrocephalus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Congenital [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74,78\">",
"       74,78",
"      </a>",
"      ] &mdash; Sometimes associated with Leber's congenital amaurosis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/94\">",
"       94",
"      </a>",
"      ]. A transient form more apparent in the supine position and with tonic downgaze deviation occurs in normal infants at about six to eight weeks of age and disappears after a few months to one year [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/95\">",
"       95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bilateral peripheral vestibular disease &mdash; Upbeat nystagmus is rarely seen with this disease [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/96\">",
"       96",
"      </a>",
"      ]. On occasion, a pure upbeat variant of benign paroxysmal positional vertigo can be found with bilateral canalithiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oscillopsia is less frequent with upbeat than with downbeat nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/55\">",
"     55",
"    </a>",
"    ]. Patients may complain of blurred vision or can be asymptomatic.",
"   </p>",
"   <p>",
"    Upbeat nystagmus occurs in the primary position and usually increases with upgaze and decreases with downgaze and sometimes convergence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/72,75\">",
"     72,75",
"    </a>",
"    ]. Rarely, it may convert into downbeat nystagmus in upgaze [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/98\">",
"     98",
"    </a>",
"    ] or when the patient is lying down with the neck extended [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75\">",
"     75",
"    </a>",
"    ]. Impaired upward pursuit is always seen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/55\">",
"     55",
"    </a>",
"    ]. Other eye movement abnormalities are variable [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/55\">",
"     55",
"    </a>",
"    ], including poor horizontal smooth pursuit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/78\">",
"     78",
"    </a>",
"    ], gaze-evoked nystagmus in 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/70,78,83,86\">",
"     70,78,83,86",
"    </a>",
"    ], and rebound nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/78\">",
"     78",
"    </a>",
"    ]. Internuclear ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75,81,84\">",
"     75,81,84",
"    </a>",
"    ], skew deviation, or ocular tilt reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/75,80,81\">",
"     75,80,81",
"    </a>",
"    ] are evident in up to half of patients. An video demonstrating upbeat nystagmus following a medial medullary infarction is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case65/case65.html\">",
"     file://www.neuroophthalmology.ca/cases/case65/case65.html",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Patients with cerebellar lesions have gait ataxia in 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/78,84\">",
"     78,84",
"    </a>",
"    ], and dysmetria, dysarthria, and truncal ataxia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/70,72,78\">",
"     70,72,78",
"    </a>",
"    ]. In those with medullary lesions, there can be palsies of the pharynx and tongue; tongue fasciculations [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/83,85,91\">",
"     83,85,91",
"    </a>",
"    ]; palatal myoclonus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/82\">",
"     82",
"    </a>",
"    ]; and pain and temperature loss in the body or face [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history in patients with upbeat nystagmus should concentrate upon:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medications, insecticide exposure, and diet",
"     </li>",
"     <li>",
"      Past history of vertigo or transient neurologic dysfunction suggesting multiple sclerosis",
"     </li>",
"     <li>",
"      Family history of gait imbalance and incoordination",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MRI is the procedure of choice, with emphasis upon the posterior fossa. The CSF should be examined if infection or inflammation is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven treatment for upbeat nystagmus. There are reports of benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/61\">",
"     61",
"    </a>",
"    ], alcohol, amytal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/99\">",
"     99",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6725?source=see_link\">",
"     dalfampridine",
"    </a>",
"    (4-aminopyridine) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/100\">",
"     100",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/101\">",
"     101",
"    </a>",
"    ]. Prisms might help patients whose nystagmus is minimized by downgaze or convergence. The course is often long-lasting [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Horizontal nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Horizontal nystagmus can occur with acquired peripheral or central vestibular lesions. Congenital nystagmus can also have a horizontal jerk waveform. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1034?source=see_link\">",
"     \"Pendular nystagmus\"",
"    </a>",
"    .) A special and unusual central form is periodic alternating nystagmus, which can be congenital or acquired.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Peripheral vestibular lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pure or nearly pure horizontal nystagmus is not uncommon following sudden unilateral loss of labyrinthine inputs from vestibular neuritis or partial neurectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. Neuritis may preferentially affect the inputs of the horizontal semicircular canal, with variable degrees of anterior canal involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/102\">",
"     102",
"    </a>",
"    ]. These two semicircular canals are innervated by the superior division of the vestibular nerve and also have a distinct blood supply, the anterior vestibular artery, which may explain sparing of both posterior semicircular canal function and hearing by a peripheral lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/104\">",
"     104",
"    </a>",
"    ]. A video demonstrating horizontal nystagmus following right vestibular infarction is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/textbook/video/nystagmusvestib.html\">",
"     file://www.neuroophthalmology.ca/textbook/video/nystagmusvestib.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Central vestibular or \"pursuit-paretic\" horizontal nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low-amplitude nystagmus in primary position is sometimes seen in patients with poor pursuit due to large cerebral lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/105\">",
"     105",
"    </a>",
"    ]. The fast phase is towards the side of the lesion. Patients are generally asymptomatic and the small nystagmus is hard to see.",
"   </p>",
"   <p>",
"    In some cases with unilateral pathology of the vestibular nuclei, horizontal nystagmus beating away from the side of the lesion is combined with abnormal smooth pursuit [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/106,107\">",
"     106,107",
"    </a>",
"    ]. However, it is not clear that these are related, or whether pursuit merely appears defective because of superimposed nystagmus. These patients usually have vertigo. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link\">",
"     \"Approach to the patient with vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Periodic alternating nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with periodic alternating nystagmus may complain of regular episodic symptoms of oscillopsia or blurred vision. The horizontal nystagmus beats in one direction for about 1 to 2 minutes, stops for 5 to 20 seconds, then beats in the other direction for another 1 to 2 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. During the oscillation the nystagmus is least when looking in the direction of the slow phase: some patients use this to minimize oscillopsia, by alternating their direction of gaze [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/108\">",
"     108",
"    </a>",
"    ]. A video demonstrating congenital periodic alternating nystagmus is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case48/case48.html\">",
"     file://www.neuroophthalmology.ca/cases/case48/case48.html",
"    </a>",
"   </p>",
"   <p>",
"    The cause of periodic alternating nystagmus is thought to be unstable storage of vestibular velocity in the cerebellum, causing hyper-responsive vestibulo-ocular responses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/63\">",
"     63",
"    </a>",
"    ]. Lesions of the nodulus and uvula in monkeys create a periodic alternating nystagmus in darkness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periodic alternating nystagmus can be congenital or acquired.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital forms have similar associations as other types of congenital nystagmus [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/110-112\">",
"       110-112",
"      </a>",
"      ], including albinism [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/113\">",
"       113",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1034?source=see_link\">",
"       \"Pendular nystagmus\"",
"      </a>",
"      .) It can occur with ataxia-telangiectasia syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/114\">",
"       114",
"      </a>",
"      ]. An X-linked infantile variant with associated strabismus and refractive errors has been described [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/115\">",
"       115",
"      </a>",
"      ]. A video demonstrating congenital periodic alternating nystagmus is available at",
"      <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case48/case48.html\">",
"       file://www.neuroophthalmology.ca/cases/case48/case48.html",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Acquired forms are associated with damage to vestibulo-cerebellar pathways, particularly Arnold-Chiari malformation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/111,112,116\">",
"       111,112,116",
"      </a>",
"      ] and cerebellar degeneration [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/111,112,117\">",
"       111,112,117",
"      </a>",
"      ], including spinocerebellar ataxia type 6 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/118\">",
"       118",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29242?source=see_link&amp;anchor=H10#H10\">",
"       \"The spinocerebellar ataxias\", section on 'SCA6'",
"      </a>",
"      .) Other causes include multiple sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/119\">",
"       119",
"      </a>",
"      ], stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/120\">",
"       120",
"      </a>",
"      ], tumors, and infections such as cryptococcosis, syphilis, and varicella encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/112\">",
"       112",
"      </a>",
"      ]. A rare autoimmune case was associated with antibodies against glutamic acid decarboxylase [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/43\">",
"       43",
"      </a>",
"      ]. Occasional cases are described with visual loss, which improve as vision improves [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/121\">",
"       121",
"      </a>",
"      ]. Additional cerebellar signs are common in patients with acquired disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Investigation for visual abnormalities is required in patients with the congenital form. With the acquired form, the main investigation is MRI of the brainstem and cerebellum, with consideration of CSF exam if infection is suspected.",
"   </p>",
"   <p>",
"    The prognosis varies with the underlying condition. In unusual cases, progression of degenerative disease may paradoxically eliminate nystagmus.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     Baclofen",
"    </a>",
"    , 10 mg three times daily, is effective treatment for the acquired form [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/108,122-124\">",
"     108,122-124",
"    </a>",
"    ]. Baclofen had been thought ineffective for the congenital form [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/125\">",
"     125",
"    </a>",
"    ], but a study of eight patients found some benefit in seven, with three continuing on treatment for several years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/126\">",
"     126",
"    </a>",
"    ]. In those who do not respond to baclofen, retrobulbar botulinum toxin injections and muscle surgery have been used [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/127\">",
"     127",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Torsional nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Torsional nystagmus is a central nystagmus caused by dysfunction of vertical semicircular canal inputs from one side [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128\">",
"     128",
"    </a>",
"    ] or possibly by otolith dysfunction. Most cases have lesions at the lateral junction of the pons and medulla that involve the vestibular nuclei [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128,129\">",
"     128,129",
"    </a>",
"    ]. Vestibular input to ocular motor centers can also be interrupted in the pons [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/130\">",
"     130",
"    </a>",
"    ] or midbrain [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/131\">",
"     131",
"    </a>",
"    ]. Torsional nystagmus can beat either towards or away from the side of the midbrain lesion, depending on which prenuclear ocular motor structure is involved [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/132\">",
"     132",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of torsional nystagmus are infarction and multiple sclerosis (",
"    <a class=\"graphic graphic_figure graphicRef81197 \" href=\"UTD.htm?38/3/38974\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128,130\">",
"     128,130",
"    </a>",
"    ]. Tumors and venous angiomata in the pons or cerebellum [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128,133,134\">",
"     128,133,134",
"    </a>",
"    ] are next most frequent. Rare causes include encephalitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128\">",
"     128",
"    </a>",
"    ], vascular compression [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/135\">",
"     135",
"    </a>",
"    ], trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128,136\">",
"     128,136",
"    </a>",
"    ], syringobulbia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/137\">",
"     137",
"    </a>",
"    ], and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/138,139\">",
"     138,139",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Torsional nystagmus is usually a constant nystagmus with oscillopsia. Episodic torsional nystagmus is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/135,140\">",
"     135,140",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The torsional movements are the same in both eyes, frequently also with a small vertical movement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/129-131,140\">",
"     129-131,140",
"    </a>",
"    ]. Torsional nystagmus can dampen with convergence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smooth pursuit is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128\">",
"     128",
"    </a>",
"    ] and skew deviation is seen in 30 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/128,131\">",
"     128,131",
"    </a>",
"    ]. Patients with a medullary lesion may have other signs of the lateral medullary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/129\">",
"     129",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=see_link&amp;anchor=H8#H8\">",
"     \"Posterior circulation cerebrovascular syndromes\", section on 'Lateral medullary infarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with pontine lesions may have internuclear ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/130,133\">",
"     130,133",
"    </a>",
"    ]; and patients with midbrain lesions may have vertical gaze palsies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI of the posterior fossa is required in all patients with torsional nystagmus. CSF examination is not helpful if signs of infection are absent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven effective treatment. One patient is reported to have improved with alternating trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Peripheral nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nystagmus due to a peripheral vestibular lesion arises from an acute or intermittent asymmetry in vestibular function, altering the normal \"push-pull\" balance between antagonistic inputs from the right versus left ear. This usually occurs with unilateral disease. Symmetric, simultaneous bilateral vestibular loss, as with aminoglycoside ototoxicity or bilateral vestibular schwannomas (acoustic neuromas), does not cause vertigo and nystagmus, but rather oscillopsia with head motion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/141\">",
"     141",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nystagmus reflects the pattern of semicircular canal dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34165?source=see_link\">",
"     \"Overview of nystagmus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unilateral vestibular lesions can affect the inputs from all three canals on one side. The resulting nystagmus has a mixed horizontal torsional waveform; either right-beat and clockwise for left-sided disease, or left-beat and counterclockwise for right-sided disease.",
"     </li>",
"     <li>",
"      Partial lesions may occur that tend to affect the horizontal and anterior canal together because of the vascular supply and neural divisions in the superior and inferior vestibular nerves. This creates a mixed horizontal, upbeat, and torsional nystagmus, or sometimes a waveform that is almost solely horizontal [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/102\">",
"       102",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Peripheral vestibular nystagmus increases with gaze in the direction of the fast phase, and decreases with gaze in the direction of the slow phase [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/142\">",
"     142",
"    </a>",
"    ]. Some grade nystagmus as first degree (only present on gaze in the direction of the fast phase), second degree (also present in primary position), and third degree (evident even with gaze in the direction of the slow phase). This correlates with severity and duration, to some degree.",
"   </p>",
"   <p>",
"    Some forms of peripheral nystagmus are due to abnormal excitation of the vestibular system rather than hypofunction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/143\">",
"     143",
"    </a>",
"    ]. The classic example is benign paroxysmal positional vertigo, which in the majority of cases is due to abnormal excitation of a posterior semicircular canal with certain head positions, leading to a mixed",
"    <span class=\"nowrap\">",
"     upbeat/torsional",
"    </span>",
"    nystagmus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=see_link\">",
"     \"Benign paroxysmal positional vertigo\"",
"    </a>",
"    .) Excitation tends to be restricted to one canal, causing either a mixed",
"    <span class=\"nowrap\">",
"     vertical/torsional",
"    </span>",
"    nystagmus if one of the vertical canals is responsible [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/143,144\">",
"     143,144",
"    </a>",
"    ], or a horizontal nystagmus if the horizontal canal is the site of the lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/145\">",
"     145",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Differentiating central and peripheral nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some features can aid in distinguishing peripheral from central vestibular nystagmus (",
"    <a class=\"graphic graphic_table graphicRef76359 \" href=\"UTD.htm?29/33/30235\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peripheral nystagmus is often accompanied by severe vertigo and vomiting. The symptoms with central nystagmus range widely from none, to mild oscillopsia, to pronounced vertigo.",
"     </li>",
"     <li>",
"      Peripheral nystagmus, even from a permanent lesion,",
"      <strong>",
"       almost always remits",
"      </strong>",
"      within a few days to weeks through central adaptive mechanisms and the development of the ability to suppress nystagmus with visual fixation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/146\">",
"       146",
"      </a>",
"      ]. Suppression can be demonstrated during fundoscopy by covering the remaining viewing eye briefly and seeing if the examined fundus starts to move more. Frenzl lenses that blur vision can be used to show this too. Central nystagmus can be persistent or remitting depending upon the lesion, and is not suppression by fixation.",
"     </li>",
"     <li>",
"      The waveform is a valuable clue. Pure downbeat, pure upbeat, or pure torsional nystagmus are almost always central brainstem signs, while pure horizontal or mixed forms of nystagmus typify peripheral disease. However, the presence of pure horizontal or mixed nystagmus cannot exclude central disease since they also occur with lesions of the vestibular nuclei in the lateral medulla. A reversal of nystagmus direction between right and left gaze indicates defective gaze-holding (see",
"      <a class=\"local\" href=\"#H24\">",
"       'Gaze-evoked nystagmus'",
"      </a>",
"      below) and points to a central cause [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/147\">",
"       147",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Accompanying hearing loss is common with peripheral nystagmus but rare with central lesions. Conversely, cerebellar and brainstem signs indicate a central lesion. However, a lack of these features cannot be used to exclude locations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     GAZE-EVOKED NYSTAGMUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gaze-evoked nystagmus is probably the most commonly encountered type of nystagmus. To maintain an eccentric eye position, increased tonic contraction of the agonist muscles is needed to oppose the elastic forces that bring the eye back to center. This \"step\" increase in neuronal firing and muscle contraction normally correlates well with the large \"pulse\" of force that shifted the eye to that position. An inadequate step after a pulse will cause the eyes to drift back to center.",
"   </p>",
"   <p>",
"    The structures involved in gaze-holding are the cerebellar flocculus, along with regions in the lateral medulla for horizontal gaze and the midbrain for vertical gaze. Rebound nystagmus (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Clinical features'",
"    </a>",
"    above) may represent a short-term adaptation by intact vestibulo-ocular pathways to counteract gaze-evoked nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/148\">",
"     148",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of gaze-evoked nystagmus include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gaze-evoked nystagmus is part of the \"floccular syndrome\" (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Downbeat nystagmus'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Toxic/metabolic",
"      </span>",
"      causes, the most common, include anticonvulsants such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      , as well as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      , and sedatives.",
"     </li>",
"     <li>",
"      Structural causes include spinocerebellar degeneration, multiple sclerosis, cerebellar or brainstem ischemia, and posterior fossa tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/147,149\">",
"       147,149",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autoimmune cerebellar syndromes such as gluten sensitivity with anti-gliadin antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/150\">",
"       150",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autosomal dominant spinocerebellar ataxias, including SCA-6, -15, and -28, among others [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/151-153\">",
"       151-153",
"      </a>",
"      ], as well as episodic ataxia type 2 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/154\">",
"       154",
"      </a>",
"      ]. Gaze-evoked nystagmus is occasionally seen in muscle and nerve disorders such as myasthenia gravis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/155\">",
"       155",
"      </a>",
"      ] and the Miller-Fisher syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only a minority of subjects with severe gaze-evoked nystagmus complain of gaze-evoked oscillopsia. Most are asymptomatic or have other complaints, such as poor balance from gait ataxia.",
"   </p>",
"   <p>",
"    Physical examination may reveal the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relatively large amplitude (greater than four degrees) nystagmus beating in the direction of gaze [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/149\">",
"       149",
"      </a>",
"      ]. This must be contrasted with normal endpoint nystagmus, in which a small degree of nystagmus in extreme gaze is seen in 50 percent of normal subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/156\">",
"       156",
"      </a>",
"      ], particularly in darkness. Physiological endpoint nystagmus also tends to fatigue with prolonged end-gaze.",
"     </li>",
"     <li>",
"      Rebound nystagmus &mdash; Lateral gaze for approximately a minute leads to a decrease of nystagmus in some patients, and when the eyes return to center there is a transient nystagmus in the opposite direction, fading over several seconds. This almost always indicates a vestibulo-cerebellar lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/14,148,157-159\">",
"       14,148,157-159",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A video demonstrating gaze-evoked and rebound nystagmus in a patient with episodic ataxia type 2 is available at",
"      <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case86/case86.html\">",
"       file://www.neuroophthalmology.ca/cases/case86/case86.html",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Associated signs &mdash; Impairment of horizontal pursuit is common [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/147\">",
"       147",
"      </a>",
"      ], sometimes with other elements of the floccular syndrome (eg, downbeat nystagmus). Other cerebellar dysfunction such as gait ataxia may be present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications must be reviewed first in patients with gaze-evoked nystagmus. MRI with focus on the posterior fossa and consideration of demyelination is recommended next.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;First-degree vestibular nystagmus is only seen when the eyes are looking to the side opposite the vestibular lesion. In contrast to the nystagmus from impaired gaze-holding, there is no nystagmus in the opposite direction; thus, gaze-evoked nystagmus in both directions implies a central lesion.",
"   </p>",
"   <p>",
"    Dissociated gaze-evoked nystagmus is a manifestation in the normal eye of central adaptation to ocular motor weakness in the other eye. This is most commonly seen in internuclear ophthalmoplegia and occasionally with VI and III nerve palsies. In internuclear ophthalmoplegia, there is a failure of adduction in one eye coupled with an abducting nystagmus in the fellow eye.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gaze-evoked nystagmus often resolves when the offending drug is stopped. Treatment is not usually needed. Associated balance problems may require physical therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Bruns' (bidirectional horizontal) nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bruns' nystagmus is a combination of mild horizontal vestibular nystagmus (usually contralateral to the lesion) in one direction of gaze, and a coarser impaired gaze-holding nystagmus in the other direction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/10\">",
"     10",
"    </a>",
"    ]. It is often accompanied by other central eye movement abnormalities, including impaired pursuit and optokinetic responses, hypermetria of saccades, and gaze-evoked nystagmus in upgaze [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/160\">",
"     160",
"    </a>",
"    ]. A video demonstrating Brun&rsquo;s nystagmus is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case44/case44.html\">",
"     file://www.neuroophthalmology.ca/cases/case44/case44.html",
"    </a>",
"   </p>",
"   <p>",
"    Bruns' nystagmus indicates a lesion at the cerebellopontine angle, which can impair both the gaze-holding network and the vestibular input from one side. It is usually caused by tumors compressing the brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/160\">",
"     160",
"    </a>",
"    ] and is seen in 15 percent of patients with cerebello-pontine angle tumors, which are often vestibular schwannomas (acoustic neuromas) but also meningiomas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/161\">",
"     161",
"    </a>",
"    ], epidermoid tumors, and arachnoid cysts. It also occurs rarely with disease in the brainstem, such as multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/162\">",
"     162",
"    </a>",
"    ] or lateral medullary infarcts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/163\">",
"     163",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI of the posterior fossa is indicated in patients with Bruns' nystagmus. The tumors that cause this disorder are always large (diameter greater than 3 cm) since brainstem compression is required [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/161\">",
"     161",
"    </a>",
"    ]. Two-thirds of patients also have abnormal brainstem auditory evoked responses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/161\">",
"     161",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurosurgical treatment is required in most patients. The prognosis varies with the etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     CONGENITAL NYSTAGMUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital nystagmus can have both pendular and jerk characteristics, even within the same patient. Nystagmus also can change with the direction of gaze. Here, we note one particular type of congenital nystagmus that is a horizontal jerk nystagmus: latent nystagmus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1034?source=see_link\">",
"     \"Pendular nystagmus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Latent nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Latent nystagmus is found in patients with childhood strabismus. It is a nystagmus that changes or appears only with monocular viewing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Latent nystagmus is asymptomatic. When one eye is covered, a conjugate jerk nystagmus appears, beating in the direction of the viewing eye (eg, left beating with left eye viewing alone). When the other eye is covered, the nystagmus reverses direction. With both eyes open there may be no nystagmus (true latent nystagmus) or, particularly in patients with amblyopia, there may be a smaller nystagmus beating towards the preferentially viewing eye (manifest latent nystagmus). A video demonstrating latent nystagmus is available at",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case73/case73.html\">",
"     file://www.neuroophthalmology.ca/cases/case73/case73.html",
"    </a>",
"    &nbsp;",
"   </p>",
"   <p>",
"    Eye movement recordings show that all latent nystagmus has a small manifest component [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/164,165\">",
"     164,165",
"    </a>",
"    ]. Nystagmus often begins as manifest in infants, gradually converting to a more latent form [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/166\">",
"     166",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to nystagmus, there are a number of associated signs in patients with latent nystagmus:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Strabismus is common, mostly esotropia, sometimes exotropia, and rarely only phoria [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/165\">",
"       165",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many patients have \"dissociated vertical deviation,\" meaning that each eye when covered deviates upward.",
"     </li>",
"     <li>",
"      Horizontal pursuit and optokinetic responses are variably affected. With monocular viewing, the response to stimuli moving temporally (from nose to temple) may be decreased; whether this causes or is caused by the nystagmus is debated [",
"      <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/167\">",
"       167",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates viewing with one eye only have an asymmetry in the optokinetic eye movements to nasally versus temporally moving stimuli. Latent nystagmus may reflect persistence of this asymmetry in patients who fail to develop binocular vision because of strabismus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/168\">",
"     168",
"    </a>",
"    ]. Monkeys raised without binocular vision develop latent nystagmus; some suggest that this is due to the failure to develop binocular innervation of midbrain regions that generate optokinetic responses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/169,170\">",
"     169,170",
"    </a>",
"    ]. Others suggest that the key problem is loss of binocular connections to striate cortex in the first months of life, and that the nystagmus results from an imbalance in binocular activity in cortical regions such as the medial superior temporal area [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/171\">",
"     171",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is evidence that manifest latent nystagmus emerges only in the absence of binocular vision since it often resolves when binocular vision is established [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/172\">",
"     172",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Etiology/differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern of nystagmus is pathognomonic. Manifest latent nystagmus can be confused with other horizontal jerk nystagmus until it is appreciated that the nystagmus reverses direction when the preferred eye is covered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;None is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Latent nystagmus persists throughout life. In a few patients it is worsened nonspecifically by unrelated diseases or minor head injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/165\">",
"     165",
"    </a>",
"    ], causing confusion until the characteristic effect of monocular viewing is discovered.",
"   </p>",
"   <p>",
"    Manifest latent nystagmus can be converted to latent nystagmus in patients with a good result from strabismus surgery or correction of refractive error, leading to better binocular visual acuity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/172\">",
"     172",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Latent nystagmus is not necessarily a contraindication to patch therapy in children with strabismus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/173\">",
"     173",
"    </a>",
"    ]. Patching over a few days can actually decrease oscillopsia and nystagmus in the viewing eye [",
"    <a class=\"abstract\" href=\"UTD.htm?23/6/23658/abstract/174\">",
"     174",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7762798\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Jerk nystagmus is a rhythmic eye oscillation characterized by a slow drift of the eyes in one direction, repeatedly corrected by fast movements in the reverse direction. In most cases the slow drift represents the problem, of which there are two main causes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A tonic imbalance in a \"slow eye movement\" system, such as the vestibular or pursuit systems. This is most often due to an acute asymmetry in vestibular activity, either peripheral or central.",
"     </li>",
"     <li>",
"      An inability to hold an eccentric eye position against the normal viscoelastic forces that tend to bring the eye back to midline (\"gaze-holding\").",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Jerk nystagmus is subdivided by trajectory and the conditions under which it occurs (",
"      <a class=\"graphic graphic_table graphicRef72446 \" href=\"UTD.htm?10/40/10892\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Nystagmus in the primary position is classified according to trajectory: downbeat; upbeat; horizontal; torsional; or mixed. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Primary position jerk nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The anatomic location and likely underlying etiology vary according to these classifications. Intoxications, structural lesions (infarction, demyelination, tumor) in the brainstem and degenerative disease are usually in the differential diagnosis. Magnetic resonance imaging is usually helpful.",
"     </li>",
"     <li>",
"      Treatment depends on the underlying cause as well as the classification.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gaze evoked nystagmus can occur as a result of toxins, structural pathology in the cerebellum or brainstem, as well as with some muscle and nerve disorders. Most patients are asymptomatic or have mild ataxia. The treatment is that of the underlying disorder or removal of the offending medication. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Gaze-evoked nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Latent nystagmus is a jerk nystagmus that is observed in patients with childhood strabismus. It is brought out on monocular examination; with both eyes open there may be no nystagmus. In addition to strabismus, many patients have dissociated vertical deviation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abnormal horizontal pursuit or optokinetic responses. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Latent nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/1\">",
"      Baloh RW, Spooner JW. Downbeat nystagmus: a type of central vestibular nystagmus. Neurology 1981; 31:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/2\">",
"      Marti S, Straumann D, Glasauer S. The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity Purkinje cells. Ann N Y Acad Sci 2005; 1039:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/3\">",
"      Halmagyi GM, Rudge P, Gresty MA, Sanders MD. Downbeating nystagmus. A review of 62 cases. Arch Neurol 1983; 40:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/4\">",
"      Yee RD. Downbeat nystagmus: characteristics and localization of lesions. Trans Am Ophthalmol Soc 1989; 87:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/5\">",
"      Wagner JN, Glaser M, Brandt T, Strupp M. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 2008; 79:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/6\">",
"      Cogan DG. Down-beat nystagmus. Arch Ophthalmol 1968; 80:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/7\">",
"      Biller J, Pagano RJ. Downbeat nystagmus and pathology at cervicomedullary junction. Neurology 1981; 31:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/8\">",
"      Jacobson DM, Corbett JJ. Downbeat nystagmus associated with dolichoectasia of the vertebrobasilar artery. Arch Neurol 1989; 46:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/9\">",
"      Pedersen RA, Troost BT, Abel LA, Zorub D. Intermittent downbeat nystagmus and oscillopsia reversed by suboccipital craniectomy. Neurology 1980; 30:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/10\">",
"      Spooner JW, Baloh RW. Arnold-Chiari malformation: improvement in eye movements after surgical treatment. Brain 1981; 104:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/11\">",
"      Senelick RC. Total alleviation of downbeat nystagmus in basilar impression by transoral removal of the odontoid process. J Clin Neuroophthalmol 1981; 1:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/12\">",
"      McConnell HW, Darlington CL, Smith PF, et al. Hereditary cerebellar degeneration with downbeat nystagmus. A case and it's treatment. Acta Neurol Scand 1990; 81:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/13\">",
"      Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/14\">",
"      Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997; 41:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/15\">",
"      H&uuml;bner J, Sprenger A, Klein C, et al. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17). Neurology 2007; 69:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/16\">",
"      Takahashi H, Ishikawa K, Tsutsumi T, et al. A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. J Hum Genet 2004; 49:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/17\">",
"      Yu-Wai-Man P, Gorman G, Bateman DE, et al. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J Neurol 2009; 256:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/18\">",
"      Migliaccio AA, Halmagyi GM, McGarvie LA, Cremer PD. Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign. Brain 2004; 127:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/19\">",
"      Gordon CR, Joffe V, Vainstein G, Gadoth N. Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease). J Neurol Neurosurg Psychiatry 2003; 74:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/20\">",
"      Szmulewicz DJ, Waterston JA, MacDougall HG, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis. Ann N Y Acad Sci 2011; 1233:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/21\">",
"      Szmulewicz DJ, Waterston JA, Halmagyi GM, et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology 2011; 76:1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/22\">",
"      Coppeto JR, Monteiro ML, Lessell S, et al. Downbeat nystagmus. Long-term therapy with moderate-dose lithium carbonate. Arch Neurol 1983; 40:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/23\">",
"      Halmagyi GM, Lessell I, Curthoys IS, et al. Lithium-induced downbeat nystagmus. Am J Ophthalmol 1989; 107:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/24\">",
"      Corbett JJ, Jacobson DM, Thompson HS, et al. Downbeating nystagmus and other ocular motor defects caused by lithium toxicity. Neurology 1989; 39:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/25\">",
"      Monteiro ML, Sampaio CM. Lithium-induced downbeat nystagmus in a patient with Arnold-Chiari malformation. Am J Ophthalmol 1993; 116:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/26\">",
"      Williams DP, Troost BT, Rogers J. Lithium-induced downbeat nystagmus. Arch Neurol 1988; 45:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/27\">",
"      Rosenberg ML. Permanent lithium-induced downbeating nystagmus. Arch Neurol 1989; 46:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/28\">",
"      Alpert JN. Downbeat nystagmus due to anticonvulsant toxicity. Ann Neurol 1978; 4:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/29\">",
"      Wheeler SD, Ramsay RE, Weiss J. Drug-induced downbeat nystagmus. Ann Neurol 1982; 12:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/30\">",
"      Chrousos GA, Cowdry R, Schuelein M, et al. Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine. Am J Ophthalmol 1987; 103:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/31\">",
"      Oh SY, Kim JS, Lee YH, et al. Downbeat, positional, and perverted head-shaking nystagmus associated with lamotrigine toxicity. J Clin Neurol 2006; 2:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/32\">",
"      Hwang TL, Still CN, Jones JE. Reversible downbeat nystagmus and ataxia in felbamate intoxication. Neurology 1995; 45:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/33\">",
"      Rosenberg ML. Reversible downbeat nystagmus secondary to excessive alcohol intake. J Clin Neuroophthalmol 1987; 7:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/34\">",
"      Costin JA, Smith JL, Emery S, Tomsak RL. Alcoholic downbeat nystagmus. Ann Ophthalmol 1980; 12:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/35\">",
"      Zasorin NL, Baloh RW. Downbeat nystagmus with alcoholic cerebellar degeneration. Arch Neurol 1984; 41:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/36\">",
"      Lavin PJ, Traccis S, Dell'Osso LF, et al. Downbeat nystagmus with a pseudocycloid waveform: improvement with base-out prisms. Ann Neurol 1983; 13:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/37\">",
"      Mayfrank L, Thoden U. Downbeat nystagmus indicates cerebellar or brain-stem lesions in vitamin B12 deficiency. J Neurol 1986; 233:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/38\">",
"      Sedehizadeh S, Keogh M, Wills AJ. Reversible hypomagnesaemia-induced subacute cerebellar syndrome. Biol Trace Elem Res 2011; 142:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/39\">",
"      Kaut O, Kornblum C. Transient downbeat nystagmus after intravenous administration of the opioid piritramide. J Neuroophthalmol 2010; 30:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/40\">",
"      Shimizu N, Weinberger J, Yahr MD. Downbeat nystagmus as a sign of brainstem involvement in acute meningoencephalitis. Neurology 1975; 25:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/41\">",
"      Hirst LW, Clark AW, Wolinsky JS, et al. Downbeat nystagmus. A case report of herpetic brain stem encephalitis. J Clin Neuroophthalmol 1983; 3:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/42\">",
"      Orwitz JI, Galetta SL, Teener JW. Bilateral trochlear nerve palsy and downbeat nystagmus in a patient with cephalic tetanus. Neurology 1997; 49:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/43\">",
"      Tilikete C, Vighetto A, Trouillas P, Honnorat J. Potential role of anti-GAD antibodies in abnormal eye movements. Ann N Y Acad Sci 2005; 1039:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/44\">",
"      Antonini G, Nemni R, Giubilei F, et al. Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus. J Neurol Neurosurg Psychiatry 2003; 74:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/45\">",
"      Zivotofsky AZ, Siman-Tov T, Gadoth N, Gordon CR. A rare saccade velocity profile in Stiff-Person Syndrome with cerebellar degeneration. Brain Res 2006; 1093:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/46\">",
"      Guy JR, Schatz NJ. Paraneoplastic downbeating nystagmus. A sign of occult malignancy. J Clin Neuroophthalmol 1988; 8:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/47\">",
"      Phadke JG, Hern JE, Blaiklock CT. Downbeat nystagmus--a false localising sign due to communicating hydrocephalus. J Neurol Neurosurg Psychiatry 1981; 44:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/48\">",
"      Bixenman WW. Congenital hereditary downbeat nystagmus. Can J Ophthalmol 1983; 18:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/49\">",
"      Brodsky MC. Congenital downbeat nystagmus. J Pediatr Ophthalmol Strabismus 1996; 33:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/50\">",
"      Gottlob I. Eye movement abnormalities in carriers of blue-cone monochromatism. Invest Ophthalmol Vis Sci 1994; 35:3556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/51\">",
"      Kattah JC, Gujrati M. Familial positional downbeat nystagmus and cerebellar ataxia: clinical and pathologic findings. Ann N Y Acad Sci 2005; 1039:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/52\">",
"      Cha YH, Lee H, Jen JC, et al. Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q. J Neurol Neurosurg Psychiatry 2007; 78:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/53\">",
"      Himi T, Kataura A, Tokuda S, et al. Downbeat nystagmus with compression of the medulla oblongata by the dolichoectatic vertebral arteries. Am J Otol 1995; 16:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/54\">",
"      H&uuml;fner K, Stephan T, Kalla R, et al. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus. Neurology 2007; 69:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/55\">",
"      Baloh RW, Yee RD. Spontaneous vertical nystagmus. Rev Neurol (Paris) 1989; 145:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/56\">",
"      Yee RD, Baloh RW, Honrubia V. Episodic vertical oscillopsia and downbeat nystagmus in a Chiari malformation. Arch Ophthalmol 1984; 102:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/57\">",
"      Chan T, Logan P, Eustace P. Intermittent downbeat nystagmus secondary to vermian arachnoid cyst with associated obstructive hydrocephalus. J Clin Neuroophthalmol 1991; 11:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/58\">",
"      Rosengart A, Hedges TR 3rd, Teal PA, et al. Intermittent downbeat nystagmus due to vertebral artery compression. Neurology 1993; 43:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/59\">",
"      Crevits, L, Reynaert, C. Downbeat nystagmus. An electro-oculographic study. Neuro-ophthalmology 1989; 9:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/60\">",
"      Glasauer S, Hoshi M, B&uuml;ttner U. Smooth pursuit in patients with downbeat nystagmus. Ann N Y Acad Sci 2005; 1039:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/61\">",
"      Dieterich M, Straube A, Brandt T, et al. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 1991; 54:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/62\">",
"      Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 1994; 35:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/63\">",
"      Currie JN, Matsuo V. The use of clonazepam in the treatment of nystagmus-induced oscillopsia. Ophthalmology 1986; 93:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/64\">",
"      Strupp M, Sch&uuml;ler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003; 61:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/65\">",
"      Sprenger A, Rambold H, Sander T, et al. Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine. Neurology 2006; 67:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/66\">",
"      Kalla R, Glasauer S, B&uuml;ttner U, et al. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 2007; 130:2441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/67\">",
"      Strupp M, Kalla R, Glasauer S, et al. Aminopyridines for the treatment of cerebellar and ocular motor disorders. Prog Brain Res 2008; 171:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/68\">",
"      Tsunemi T, Ishikawa K, Tsukui K, et al. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia. J Neurol Sci 2010; 292:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/69\">",
"      Sander T, Sprenger A, Marti S, et al. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus. J Neurol 2011; 258:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/70\">",
"      Nakada T, Remler MP. Primary position upbeat nystagmus. Another central vestibular nystagmus? J Clin Neuroophthalmol 1981; 1:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/71\">",
"      Kattah JC, Dagi TF. Compensatory head tilt in upbeating nystagmus. J Clin Neuroophthalmol 1990; 10:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/72\">",
"      Fisher A, Gresty M, Chambers B, Rudge P. Primary position upbeating nystagmus. A variety of central positional nystagmus. Brain 1983; 106 ( Pt 4):949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/73\">",
"      Keane JR, Itabashi HH. Upbeat nystagmus: clinicopathologic study of two patients. Neurology 1987; 37:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/74\">",
"      Tokomasu, K, Fujino, A, Yoshio, S, et al. Upbeat nystagmus in primary eye position. Acta Otolaryngol 1991; 481:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/75\">",
"      Kim JS, Yoon B, Choi KD, et al. Upbeat nystagmus: clinicoanatomical correlations in 15 patients. J Clin Neurol 2006; 2:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/76\">",
"      Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain 2005; 128:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/77\">",
"      Saito T, Aizawa H, Sawada J, et al. Lesion of the nucleus intercalatus in primary position upbeat nystagmus. Arch Neurol 2010; 67:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/78\">",
"      Yamane M, Mizuno M, Futaki T. Analysis of neuro-otological manifestations in patients with upbeat or downbeat nystagmus. Acta Otolaryngol Suppl 1991; 481:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/79\">",
"      Kattah JC, Kolsky MP, Guy J, O'Doherty D. Primary position vertical nystagmus and cerebellar ataxia. Arch Neurol 1983; 40:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/80\">",
"      Munro NA, Gaymard B, Rivaud S, et al. Upbeat nystagmus in a patient with a small medullary infarct. J Neurol Neurosurg Psychiatry 1993; 56:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/81\">",
"      Hankey GJ, Silbert PL, Edis RH. Localising value of primary position upbeating nystagmus. Aust N Z J Med 1987; 17:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/82\">",
"      Hirose G, Kawada J, Tsukada K, et al. Upbeat nystagmus: clinicopathological and pathophysiological considerations. J Neurol Sci 1991; 105:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/83\">",
"      Rousseaux M, Dupard T, Lesoin F, et al. Upbeat and downbeat nystagmus occurring successively in a patient with posterior medullary haemorrhage. J Neurol Neurosurg Psychiatry 1991; 54:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/84\">",
"      Troost BT, Martinez J, Abel LA, Heros RC. Upbeat nystagmus and internuclear ophthalmoplegia with brainstem glioma. Arch Neurol 1980; 37:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/85\">",
"      Gilman N, Baloh RW, Tomiyasu U. Primary position upbeat nystagmus. A clinicopathologic study. Neurology 1977; 27:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/86\">",
"      Traccis S, Rosati G, Aiello I, et al. Upbeat nystagmus as an early sign of cerebellar astrocytoma. J Neurol 1989; 236:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/87\">",
"      Holmes GL, Hafford J, Zimmerman AW. Primary position upbeat nystagmus following meningitis. Ann Ophthalmol 1981; 13:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/88\">",
"      Vulliemoz S, Vanini G, Truffert A, et al. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 2007; 78:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/89\">",
"      Wray SH, Martinez-Hernandez E, Dalmau J, et al. Paraneoplastic upbeat nystagmus. Neurology 2011; 77:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/90\">",
"      Cox TA, Corbett JJ, Thompson HS, Lennarson L. Upbeat nystagmus changing to downbeat nystagmus with convergence. Neurology 1981; 31:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/91\">",
"      Sakuma A, Kato I, Ogino S, et al. Primary position upbeat nystagmus with special reference to alteration to downbeat nystagmus. Acta Otolaryngol Suppl 1996; 522:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/92\">",
"      Fish DJ, Rosen SM. Epidural opioids as a cause of vertical nystagmus. Anesthesiology 1990; 73:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/93\">",
"      Jay WM, Marcus RW, Jay MS. Primary position upbeat nystagmus with organophosphate poisoning. J Pediatr Ophthalmol Strabismus 1982; 19:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/94\">",
"      Hoyt, CS, Gelbart, SS. Vertical nystagmus in infants with congenital ocular abnormalities. Ophthalmic Pediatr Genet 1984; 43:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/95\">",
"      Goldblum TA, Effron LA. Upbeat nystagmus associated with tonic downward deviation in healthy neonates. J Pediatr Ophthalmol Strabismus 1994; 31:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/96\">",
"      Gresty, MA, Bronstein, AM, Brookes, GB, Rudge, P. Primary position upbeat nystagmus associated with middle ear disease. Neuro-ophthalmology 1988; 8:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/97\">",
"      Beyea JA, Parnes LS. Purely vertical upbeat nystagmus in bilateral posterior canal benign paroxysmal positional vertigo: a case report. Laryngoscope 2010; 120:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/98\">",
"      Shin BS, Oh SY, Kim JS, et al. Upbeat nystagmus changes to downbeat nystagmus with upward gaze in a patient with Wernicke's encephalopathy. J Neurol Sci 2010; 298:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/99\">",
"      BENDER MB, GORMAN WF. Vertical nystagmus on direct forward gaze with vertical oscillopsia. Am J Ophthalmol 1949; 32:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/100\">",
"      Glasauer S, Kalla R, B&uuml;ttner U, et al. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 2005; 76:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/101\">",
"      Thurtell MJ, Joshi AC, Leone AC, et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol 2010; 67:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/102\">",
"      Fetter M, Dichgans J. Vestibular neuritis spares the inferior division of the vestibular nerve. Brain 1996; 119 ( Pt 3):755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/103\">",
"      B&ouml;hmer A, Straumann D, Fetter M. Three-dimensional analysis of spontaneous nystagmus in peripheral vestibular lesions. Ann Otol Rhinol Laryngol 1997; 106:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/104\">",
"      Sando I, Black FO, Hemenway WG. Spatial distribution of vestibular nerve in internal auditory canal. Ann Otol Rhinol Laryngol 1972; 81:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/105\">",
"      Sharpe JA, Lo AW, Rabinovitch HE. Control of the saccadic and smooth pursuit systems after cerebral hemidecortication. Brain 1979; 102:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/106\">",
"      Abel LA, Daroff RB, Dell'Osso LF. Horizontal pursuit defect nystagmus. Ann Neurol 1979; 5:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/107\">",
"      Alpert JN, Daroff RB, Dell 'Osso FL, Abel LA. Pursuit defect nystagmus. Left vestibular involvement. Ann Neurol 1979; 6:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/108\">",
"      Troost BT, Janton F, Weaver R. Periodic alternating oscillopsia: a symptom of alternating nystagmus abolished by baclofen. J Clin Neuroophthalmol 1990; 10:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/109\">",
"      Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibulo-ocular reflex by the nodulus and uvula. Science 1985; 228:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/110\">",
"      Davis DG, Smith JL. Periodic alternating nystagmus. A report of eight cases. Am J Ophthalmol 1971; 72:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/111\">",
"      Baloh RW, Honrubia V, Konrad HR. Periodic alternating nystagmus. Brain 1976; 99:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/112\">",
"      Furman JM, Wall C 3rd, Pang DL. Vestibular function in periodic alternating nystagmus. Brain 1990; 113 ( Pt 5):1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/113\">",
"      Abadi RV, Pascal E. Periodic alternating nystagmus in humans with albinism. Invest Ophthalmol Vis Sci 1994; 35:4080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/114\">",
"      Shaikh AG, Marti S, Tarnutzer AA, et al. Gaze fixation deficits and their implication in ataxia-telangiectasia. J Neurol Neurosurg Psychiatry 2009; 80:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/115\">",
"      Hertle RW, Yang D, Kelly K, et al. X-linked infantile periodic alternating nystagmus. Ophthalmic Genet 2005; 26:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/116\">",
"      Leigh RJ, Robinson DA, Zee DS. A hypothetical explanation for periodic alternating nystagmus: instability in the optokinetic-vestibular system. Ann N Y Acad Sci 1981; 374:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/117\">",
"      Plant GT. Periodic alternating nystagmus in a case of hereditary ataxia and its treatment with baclofen. J Neurol Neurosurg Psychiatry 1982; 45:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/118\">",
"      Hashimoto T, Sasaki O, Yoshida K, et al. Periodic alternating nystagmus and rebound nystagmus in spinocerebellar ataxia type 6. Mov Disord 2003; 18:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/119\">",
"      Keane JR. Periodic alternating nystagmus with downward beating nystagmus. A clinicoanatomical case study of multiple sclerosis. Arch Neurol 1974; 30:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/120\">",
"      Jeong HS, Oh JY, Kim JS, et al. Periodic alternating nystagmus in isolated nodular infarction. Neurology 2007; 68:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/121\">",
"      Cross SA, Smith JL, Norton EW. Periodic alternating nystagmus clearing after vitrectomy. J Clin Neuroophthalmol 1982; 2:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/122\">",
"      Larmande P. Baclofen as a treatment for nystagmus. Ann Neurol 1982; 11:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/123\">",
"      DiBartolomeo JR, Yee RD. Periodic alternating nystagmus. Otolaryngol Head Neck Surg 1988; 99:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/124\">",
"      Halmagyi GM, Rudge P, Gresty MA, et al. Treatment of periodic alternating nystagmus. Ann Neurol 1980; 8:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/125\">",
"      Gradstein L, Reinecke RD, Wizov SS, Goldstein HP. Congenital periodic alternating nystagmus. Diagnosis and Management. Ophthalmology 1997; 104:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/126\">",
"      Comer RM, Dawson EL, Lee JP. Baclofen for patients with congenital periodic alternating nystagmus. Strabismus 2006; 14:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/127\">",
"      Thomas R, Mathai A, Braganza A, Billson F. Periodic alternating nystagmus treated with retrobulbar botulinum toxin and large horizontal muscle recession. Indian J Ophthalmol 1996; 44:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/128\">",
"      Lopez L, Bronstein AM, Gresty MA, et al. Torsional nystagmus. A neuro-otological and MRI study of thirty-five cases. Brain 1992; 115 ( Pt 4):1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/129\">",
"      Morrow MJ, Sharpe JA. Torsional nystagmus in the lateral medullary syndrome. Ann Neurol 1988; 24:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/130\">",
"      Dehaene I, Casselman JW, D'Hooghe M, Van Zandijcke M. Unilateral internuclear ophthalmoplegia and ipsiversive torsional nystagmus. J Neurol 1996; 243:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/131\">",
"      Helmchen C, Glasauer S, Bartl K, B&uuml;ttner U. Contralesionally beating torsional nystagmus in a unilateral rostral midbrain lesion. Neurology 1996; 47:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/132\">",
"      Helmchen C, Rambold H, Kempermann U, et al. Localizing value of torsional nystagmus in small midbrain lesions. Neurology 2002; 59:1956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/133\">",
"      Noseworthy JH, Ebers GC, Leigh RJ, Dell'Osso LF. Torsional nystagmus: quantitative features and possible pathogenesis. Neurology 1988; 38:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/134\">",
"      FitzGibbon EJ, Calvert PC, Dieterich M, et al. Torsional nystagmus during vertical pursuit. J Neuroophthalmol 1996; 16:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/135\">",
"      Straube A, B&uuml;ttner U, Brandt T. Recurrent attacks with skew deviation, torsional nystagmus, and contraction of the left frontalis muscle. Neurology 1994; 44:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/136\">",
"      Sabin TD, Poche JA. Pure torsional nystagmus as a consequence of head trauma. J Neurol Neurosurg Psychiatry 1969; 32:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/137\">",
"      Weissman, JD, Seidman, SH, Dell'Osso, LF, et al. Torsional, see-saw, 'bow-tie' nystagmus in association with brain stem abnormalities. Neuro-ophthalmology 1990; 10:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/138\">",
"      Horita H, Hoashi E, Okuyama Y, et al. The studies of the attacks of abnormal eye movement in a case of infantile spasms. Folia Psychiatr Neurol Jpn 1977; 31:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/139\">",
"      Jacome DE. Periodic complexes and alternating rotatory nystagmus with cyclic pupillary changes. Clin Electroencephalogr 1989; 20:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/140\">",
"      Lueck CJ, Hamlyn P, Crawford TJ, et al. A case of ocular tilt reaction and torsional nystagmus due to direct stimulation of the midbrain in man. Brain 1991; 114 ( Pt 5):2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/141\">",
"      BENDER MB. OSCILLOPSIA. Arch Neurol 1965; 13:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/142\">",
"      Robinson DA, Zee DS, Hain TC, et al. Alexander's law: its behavior and origin in the human vestibulo-ocular reflex. Ann Neurol 1984; 16:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/143\">",
"      Hughes CA, Proctor L. Benign paroxysmal positional vertigo. Laryngoscope 1997; 107:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/144\">",
"      Herdman SJ, Tusa RJ. Complications of the canalith repositioning procedure. Arch Otolaryngol Head Neck Surg 1996; 122:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/145\">",
"      De la Meilleure G, Dehaene I, Depondt M, et al. Benign paroxysmal positional vertigo of the horizontal canal. J Neurol Neurosurg Psychiatry 1996; 60:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/146\">",
"      Smith PF, Curthoys IS. Mechanisms of recovery following unilateral labyrinthectomy: a review. Brain Res Brain Res Rev 1989; 14:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/147\">",
"      B&uuml;ttner U, Grundei T. Gaze-evoked nystagmus and smooth pursuit deficits: their relationship studied in 52 patients. J Neurol 1995; 242:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/148\">",
"      Bondar RL, Sharpe JA, Lewis AJ. Rebound nystagmus in olivocerebellar atrophy: a clinicopathological correlation. Ann Neurol 1984; 15:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/149\">",
"      Zee DS, Yee RD, Cogan DG, et al. Ocular motor abnormalities in hereditary cerebellar ataxia. Brain 1976; 99:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/150\">",
"      B&uuml;rk K, B&ouml;sch S, M&uuml;ller CA, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001; 124:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/151\">",
"      Cagnoli C, Mariotti C, Taroni F, et al. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain 2006; 129:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/152\">",
"      Gardner RJ, Knight MA, Hara K, et al. Spinocerebellar ataxia type 15. Cerebellum 2005; 4:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/153\">",
"      Gomez CM, Thompson RM, Gammack JT, et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997; 42:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/154\">",
"      Kim JM, Kim JS, Ki CS, Jeon BS. Episodic Ataxia Type 2 due to a Deletion Mutation in the CACNA1A Gene in a Korean Family. J Clin Neurol 2006; 2:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/155\">",
"      Keane JR, Hoyt WF. Myasthenic (vertical) nystagmus. Verification by edrophonium tonography. JAMA 1970; 212:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/156\">",
"      Shallo-Hoffmann J, Schwarze H, Simonsz HJ, M&uuml;hlendyck H. A reexamination of end-point and rebound nystagmus in normals. Invest Ophthalmol Vis Sci 1990; 31:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/157\">",
"      Yamazaki A, Zee DS. Rebound nystagmus: EOG analysis of a case with a floccular tumour. Br J Ophthalmol 1979; 63:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/158\">",
"      Morales-Garcia C, Cardenas JL, Arriagada C, Otte J. Clinical significance of rebound nystagmus in neuro-otological diagnosis. Ann Otol Rhinol Laryngol 1978; 87:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/159\">",
"      Harris CM, Walker J, Shawkat F, et al. Eye movements in a familial vestibulocerebellar disorder. Neuropediatrics 1993; 24:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/160\">",
"      Nedzelski JM. Cerebellopontine angle tumors: bilateral flocculus compression as cause of associated oculomotor abnormalities. Laryngoscope 1983; 93:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/161\">",
"      Croxson GR, Moffat DA, Baguley D. Bruns bidirectional nystagmus in cerebellopontine angle tumours. Clin Otolaryngol Allied Sci 1988; 13:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/162\">",
"      Sasaki O, Ootsuka K, Taguchi K, Kikukawa M. Multiple sclerosis presented acute hearing loss and vertigo. ORL J Otorhinolaryngol Relat Spec 1994; 56:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/163\">",
"      Takahashi S, Takahashi J, Kikuchi T, et al. [Lateral medullary syndrome due to cavernous malformation in the brain stem]. Rinsho Shinkeigaku 1993; 33:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/164\">",
"      Dell'Osso LF, Schmidt D, Daroff RB. Latent, manifest latent, and congenital nystagmus. Arch Ophthalmol 1979; 97:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/165\">",
"      Gresty MA, Metcalfe T, Timms C, et al. Neurology of latent nystagmus. Brain 1992; 115 ( Pt 5):1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/166\">",
"      Harcourt B, Mein J, Johnson F. Natural history and associations of dissociated vertical divergence. Trans Ophthalmol Soc U K 1980; 100:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/167\">",
"      Dickinson CM, Abadi RV. Pursuit and optokinetic responses in latent/manifest latent nystagmus. Invest Ophthalmol Vis Sci 1990; 31:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/168\">",
"      Schor CM. Subcortical binocular suppression affects the development of latent and optokinetic nystagmus. Am J Optom Physiol Opt 1983; 60:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/169\">",
"      Tusa RJ, Repka MX, Smith CB, Herdman SJ. Early visual deprivation results in persistent strabismus and nystagmus in monkeys. Invest Ophthalmol Vis Sci 1991; 32:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/170\">",
"      Kaminski HJ, Leigh RJ. International Symposium for Therapy of Ocular Motility and Related Visual Disturbances. Neurology 1997; 48:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/171\">",
"      Tychsen L, Richards M, Wong A, et al. The neural mechanism for Latent (fusion maldevelopment) nystagmus. J Neuroophthalmol 2010; 30:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/172\">",
"      Zubcov AA, Reinecke RD, Gottlob I, et al. Treatment of manifest latent nystagmus. Am J Ophthalmol 1990; 110:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/173\">",
"      von Noorden GK, Avilla C, Sidikaro Y, LaRoche R. Latent nystagmus and strabismic amblyopia. Am J Ophthalmol 1987; 103:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/6/23658/abstract/174\">",
"      Simonsz HJ, Kommerell G. The effect of prolonged monocular occlusion on latent nystagmus in the treatment of amblyopia. Bull Soc Belge Ophtalmol 1989; 232:7.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5108 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.14-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23658=[""].join("\n");
var outline_f23_6_23658=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7762798\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRIMARY POSITION JERK NYSTAGMUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Downbeat nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Upbeat nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Horizontal nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Peripheral vestibular lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Central vestibular or \"pursuit-paretic\" horizontal nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Periodic alternating nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Torsional nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Etiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Peripheral nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Differentiating central and peripheral nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      GAZE-EVOKED NYSTAGMUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Bruns' (bidirectional horizontal) nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      CONGENITAL NYSTAGMUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Latent nystagmus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Etiology/differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7762798\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5108\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5108|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/51/3903\" title=\"figure 1\">",
"      Causes of downbeat nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/19/17715\" title=\"figure 2\">",
"      Head thrust test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/40/19087\" title=\"figure 3\">",
"      Causes of upbeat nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/3/38974\" title=\"figure 4\">",
"      Causes of torsional nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5108|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/40/10892\" title=\"table 1\">",
"      Classification of jerk nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/33/30235\" title=\"table 2\">",
"      Clinical features of central versus peripheral vertigo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=related_link\">",
"      Approach to the patient with vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=related_link\">",
"      Benign paroxysmal positional vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34165?source=related_link\">",
"      Overview of nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1034?source=related_link\">",
"      Pendular nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=related_link\">",
"      Posterior circulation cerebrovascular syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29242?source=related_link\">",
"      The spinocerebellar ataxias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_6_23659="Guidelines for spacing live and inactivated antigens";
var content_f23_6_23659=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59103&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59103&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Guidelines for spacing of live and inactivated antigens",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antigen combination",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommended minimum interval between doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two or more inactivated*",
"       </td>",
"       <td>",
"        May be administered simultaneously or at any interval between doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inactivated and live",
"       </td>",
"       <td>",
"        May be administered simultaneously or at any interval between doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two or more live injectable",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        28 days minimum interval, if not administered simultaneously",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Certain experts suggest a 28-day interval between tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine and tetravalent meningococcal conjugate vaccine if they are not administered simultaneously.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Live oral vaccines (eg, Ty21a typhoid vaccine and rotavirus vaccine) may be administered simultaneously or at any interval before or after inactivated or live injectable vaccines.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and Prevention. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60(RR-2):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23659=[""].join("\n");
var outline_f23_6_23659=null;
var title_f23_6_23660="Uncommon causes of liver TPL";
var content_f23_6_23660=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Uncommon indications for liver transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of Disease",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"1\">",
"        Causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        Hepatic tumors",
"       </td>",
"       <td>",
"        Carcinoid tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epithelioid hemangioendothelioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrolamellar hepatoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic adenoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatoblastoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatocellular carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic islet cell tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"10\">",
"        Metabolic and genetic disorders",
"       </td>",
"       <td>",
"        Alpha-1-antitrypsin deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystic fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glycogen storage diseases I and IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crigler-Najjar syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial hypercholesterolemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemochromatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Galactosemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemophilia A and B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Byler's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Homozygous hyperlipidemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Vascular disorders",
"       </td>",
"       <td>",
"        Budd-Chiari syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Veno-occlusive disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"9\">",
"        Miscellaneous",
"       </td>",
"       <td>",
"        Adult polycystic liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alagille syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nodular regenerative hyperplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Caroli's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe graft-versus-host disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphangiomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amyloidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic trauma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Lopez, RR, Howard, TK, Villamil, FG, et al. Liver transplantation. In: Liver and Biliary diseases, Kaplowitz, N (Ed), 1996, p. 629, and Rosen, HR, Shackleton, CR, Martin, P, Med Clin North Am 1996; 80:1069.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23660=[""].join("\n");
var outline_f23_6_23660=null;
var title_f23_6_23661="Purine nucleotide cycle";
var content_f23_6_23661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Purine nucleotide cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 176px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic showing the purine nucleotide cycle; this pathway catalyzes the conversion of two adenosine diphosphate (ADP) molecules into one molecule of adenosine triphosphate (ATP) and one molecule of adenosine monophosphate (AMP). The AMP may then be deaminated to inosine monophosphate (IMP) by myoadenylate deaminase, with concurrent production of ammonia. The enzymes involved are: 1, myodenylate deaminase (MADA); 2, adenylosuccinate synthetase; 3, adenylosuccinate lyase; 4, ATPase; 5, muscle adenylate kinase.",
"    <div class=\"footnotes\">",
"     GDP: guanosine 5'-diphosphate; GTP: guanosine 5' triphosphate.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23661=[""].join("\n");
var outline_f23_6_23661=null;
var title_f23_6_23662="Oral antipsychotics cost comparison";
var content_f23_6_23662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F51828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F51828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Oral antipsychotics US cost comparison",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Usual dosage*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Retail cost of 30 day supply",
"        <sup>",
"         &bull;",
"        </sup>",
"        ($US)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        First-generation",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chlorpromazine",
"       </td>",
"       <td>",
"        200 mg twice per day",
"       </td>",
"       <td>",
"        34.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fluphenazine",
"       </td>",
"       <td>",
"        10 mg once per day",
"       </td>",
"       <td>",
"        4.",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Haloperidol",
"       </td>",
"       <td>",
"        5 mg twice per day",
"       </td>",
"       <td>",
"        4.",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Perphenazine",
"       </td>",
"       <td>",
"        24 mg per day in 2 or 3 divided doses",
"       </td>",
"       <td>",
"        115.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thioridazine",
"       </td>",
"       <td>",
"        150 mg twice per day",
"       </td>",
"       <td>",
"        35.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thiothixene",
"       </td>",
"       <td>",
"        10 mg twice per day",
"       </td>",
"       <td>",
"        48.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trifluoperazine",
"       </td>",
"       <td>",
"        10 mg twice per day",
"       </td>",
"       <td>",
"        56.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Second-generation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Aripiprazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Abilify",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 to 30 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        584. to 816.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Orally disintegrating tablet: Abilify Discmelt",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        631.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Asenapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Sublingual tablet: Saphris",
"       </td>",
"       <td class=\"sublist_other\">",
"        5 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        753.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Clozapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        100 to 200 mg three times per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        308. to 568.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Clozaril",
"       </td>",
"       <td class=\"sublist_other\">",
"        100 to 200 mg three times per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        973. to 1947.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Orally disintegrating tablet: FazaClo",
"       </td>",
"       <td class=\"sublist_other\">",
"        100 to 200 mg three times per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        817 to 1287.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Iloperidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Fanapt",
"       </td>",
"       <td class=\"sublist_other\">",
"        6 to 12 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        836.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Lurasidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Latuda",
"       </td>",
"       <td class=\"sublist_other\">",
"        40 to 80 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        603.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Olanzapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 to 20 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        17. to 28.",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Zyprexa",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 to 20 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        622. to 1248.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Orally disintegrating tablet: Zyprexa Zydis",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        660.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Paliperidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Invega",
"       </td>",
"       <td class=\"sublist_other\">",
"        6 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        563.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Quetiapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        200 to 300 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        28. to 36.",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Seroquel",
"       </td>",
"       <td class=\"sublist_other\">",
"        200 to 300 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        716. to 970.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Seroquel XR",
"       </td>",
"       <td class=\"sublist_other\">",
"        400 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        1023.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Risperidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        12.",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Risperdal",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        473.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\" colspan=\"3\">",
"        Orally disintegrating tablet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        346.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Risperdal M-Tab",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        543.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Oral solution generic 1 mg/mL (120 mL)",
"       </td>",
"       <td class=\"sublist_other\">",
"        4 mg once per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        504.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Ziprasidone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Generic",
"       </td>",
"       <td class=\"sublist_other\">",
"        40 to 80 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        525. to 645.",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Geodon",
"       </td>",
"       <td class=\"sublist_other\">",
"        40 to 80 mg twice per day",
"       </td>",
"       <td class=\"sublist_other\">",
"        521. to 665.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    To help patients manage medication costs, refer to UpToDate patient information topics: Reducing the costs of medicines (Basics) and (Beyond the Basics). Trade names of medications shown are those available in US and some other countries.",
"    <div class=\"footnotes\">",
"     * Usual oral daily maintenance dosage for schizophrenia used for determining cost of treatment. For dosing recommendations, refer to appropriate UpToDate treatment topic.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Retail prices from",
"     <a href=\"file://www.drugstore.com\" target=\"_blank\">",
"      www.drugstore.com",
"     </a>",
"     (except where noted otherwise) in US dollars for 30 days' treatment at daily dose shown with NO prescription drug coverage according to Lexicomp online Wolters Kluwer Health &copy; 2013, accessed January 11, 2013.",
"     <br/>",
"     &Delta; Cost of generic preparations.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Price at pharmacy department of some large retail chain stores (eg, Target, Wal-Mart $4 generic drug list).",
"     <br/>",
"     &sect; Price at Costco.com pharmacy accessed on January 11, 2013 at:",
"     <a href=\"file://www2.costco.com/Pharmacy/DrugInformation.aspx?p=1\" target=\"_blank\">",
"      file://www2.costco.com/Pharmacy/DrugInformation.aspx?p=1",
"     </a>",
"     .",
"     <br/>",
"     &yen; Average wholesale price according to Medi-Span Price Rx database Wolters Kluwer Health &copy; 2013, accessed January 11, 2013.",
"    </div>",
"    <div class=\"reference\">",
"     Original table reprinted with special permission from: The Medical Letter on Drugs and Therapeutics, February 22, 2010; Vol. 52 (1332):13. www.medicalletter.org. Updated cost information and additional data revised for 2013, sourced as shown above.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23662=[""].join("\n");
var outline_f23_6_23662=null;
var title_f23_6_23663="Abnormal CFTR function in CF";
var content_f23_6_23663=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Defects in the CFTR gene in cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 306px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the biosynthesis and function of CFTR in an epithelial cell and of mechanisms of dysfunction associated with different cystic fibrosis mutations.",
"    <div class=\"footnotes\">",
"     CFTR: cystic fibrosis transmembrane conductance regulator; ER: endoplasmic reticulum; PKA: phosphokinase A; NB01 and NB02: nuclear binding folds.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Welsh, MJ, Tsui, L-C, Boat, T, Beaudet, AL. Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Disease, Scriver, CR, Beaudet, AL, Sly, WS, et al (Eds), McGraw-Hill, New York, 1995, p. 3801.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_6_23663=[""].join("\n");
var outline_f23_6_23663=null;
